<body><div><ix:header><ix:hidden><ix:nonnumeric>false</ix:nonnumeric><ix:nonnumeric>2025</ix:nonnumeric><ix:nonnumeric>Q3</ix:nonnumeric><ix:nonnumeric>0000320193</ix:nonnumeric><ix:nonnumeric>--09-27</ix:nonnumeric><ix:nonnumeric>P1Y</ix:nonnumeric><ix:nonnumeric>P1Y</ix:nonnumeric><ix:nonnumeric>P1Y</ix:nonnumeric><ix:nonnumeric>P1Y</ix:nonnumeric></ix:hidden><ix:resources><xbrli:unit><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit><xbrli:divide><xbrli:unitnumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitnumerator><xbrli:unitdenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitdenominator></xbrli:divide></xbrli:unit><xbrli:unit><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit><xbrli:measure>aapl:Customer</xbrli:measure></xbrli:unit><xbrli:unit><xbrli:measure>aapl:Vendor</xbrli:measure></xbrli:unit><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:A0.000Notesdue2025Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:A1.625NotesDue2026Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:A2.000NotesDue2027Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:A1.375NotesDue2029Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:A3.050NotesDue2029Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:A0.500Notesdue2031Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:A3.600NotesDue2042Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-07-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ProductMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ServiceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ServiceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ServiceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ServiceMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:IPhoneMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:IPhoneMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:IPhoneMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:IPhoneMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:MacMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:MacMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:MacMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:MacMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:IPadMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:IPadMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:IPadMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:IPadMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:WearablesHomeandAccessoriesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:WearablesHomeandAccessoriesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:WearablesHomeandAccessoriesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:WearablesHomeandAccessoriesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:typedmember><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2025-06-29</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:typedmember><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2026-06-28</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:typedmember><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2027-06-27</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:typedmember><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2028-07-02</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CashMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:MoneyMarketFundsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:MutualFundMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:BankTimeDepositsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CommercialPaperMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CashMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:MoneyMarketFundsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:MutualFundMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:USTreasurySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:BankTimeDepositsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CommercialPaperMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:UnfavorableInvestigationOutcomeEUStateAidRulesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:MarketableDebtSecuritiesOtherThanAssetBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:InterestRateContractMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:ForeignExchangeContractMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:TradeAccountsReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:CustomerOneMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:TradeAccountsReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:CustomerTwoMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:TradeAccountsReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:CellularNetworkCarriersMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:TradeAccountsReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:CellularNetworkCarriersMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:TradeAccountsReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-09-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>aapl:NonTradeReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:VendorOneMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>aapl:NonTradeReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:VendorTwoMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>aapl:NonTradeReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>aapl:NonTradeReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:VendorOneMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>aapl:NonTradeReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-09-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:VendorTwoMember</xbrldi:explicitmember><xbrldi:explicitmember>us-gaap:CreditConcentrationRiskMember</xbrldi:explicitmember><xbrldi:explicitmember>aapl:NonTradeReceivableMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-09-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommercialPaperMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CommercialPaperMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:AmericasSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:AmericasSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:AmericasSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:AmericasSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:EuropeSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:EuropeSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:EuropeSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:EuropeSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:GreaterChinaSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:GreaterChinaSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:GreaterChinaSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:GreaterChinaSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:JapanSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:JapanSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:JapanSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:JapanSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:RestOfAsiaPacificSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:RestOfAsiaPacificSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:RestOfAsiaPacificSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>aapl:RestOfAsiaPacificSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CorporateNonSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2025-03-30</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CorporateNonSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-03-31</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CorporateNonSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2024-09-29</xbrli:startdate><xbrli:enddate>2025-06-28</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context><xbrli:entity><xbrli:identifier>0000320193</xbrli:identifier><xbrli:segment><xbrldi:explicitmember>us-gaap:CorporateNonSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-10-01</xbrli:startdate><xbrli:enddate>2024-06-29</xbrli:enddate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div><div><br/></div></div><div>UNITED STATES</div><div>SECURITIES AND EXCHANGE COMMISSION</div><div>Washington, D.C. 20549</div><div>FORM <ix:nonnumeric>10-Q</ix:nonnumeric></div><div>(Mark One)</div><div><ix:nonnumeric></ix:nonnumeric> QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div><div>For the quarterly period ended <ix:nonnumeric>June28, 2025</ix:nonnumeric></div><div>or</div><div><ix:nonnumeric></ix:nonnumeric> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div><div>For the transition period from  to .</div><div>Commission File Number: <ix:nonnumeric>001-36743</ix:nonnumeric></div><div><img/></div><div><ix:nonnumeric>Apple Inc.</ix:nonnumeric></div><div>(Exact name of Registrant as specified in its charter)</div><div><table><tr><td><ix:nonnumeric>California</ix:nonnumeric></td><td><ix:nonnumeric>94-2404110</ix:nonnumeric></td></tr><tr><td>(State or other jurisdiction<br/>of incorporation or organization)</td><td>(I.R.S. Employer Identification No.)</td></tr><tr><td><ix:nonnumeric>One Apple Park Way</ix:nonnumeric></td></tr><tr><td><div><ix:nonnumeric>Cupertino</ix:nonnumeric>, <ix:nonnumeric>California</ix:nonnumeric></div></td><td><ix:nonnumeric>95014</ix:nonnumeric></td></tr><tr><td>(Address of principal executive offices)</td><td>(Zip Code)</td></tr></table></div><div>(<ix:nonnumeric>408</ix:nonnumeric>) <ix:nonnumeric>996-1010</ix:nonnumeric></div><div>(Registrants telephone number, including area code)</div><div>Securities registered pursuant to Section 12(b) of the Act:</div><div><table><tr><td>Title of each class</td><td>Trading symbol(s)</td><td>Name of each exchange on which registered</td></tr><tr><td><div><ix:nonnumeric>Common Stock, $0.00001 par value per share</ix:nonnumeric></div></td><td><ix:nonnumeric>AAPL</ix:nonnumeric></td><td><ix:nonnumeric>The Nasdaq Stock Market LLC</ix:nonnumeric></td></tr><tr><td><ix:nonnumeric>0.000% Notes due 2025</ix:nonnumeric></td><td><ix:nonnumeric></ix:nonnumeric></td><td><ix:nonnumeric>The Nasdaq Stock Market LLC</ix:nonnumeric></td></tr><tr><td><ix:nonnumeric>1.625% Notes due 2026</ix:nonnumeric></td><td><ix:nonnumeric></ix:nonnumeric></td><td><ix:nonnumeric>The Nasdaq Stock Market LLC</ix:nonnumeric></td></tr><tr><td><ix:nonnumeric>2.000% Notes due 2027</ix:nonnumeric></td><td><ix:nonnumeric></ix:nonnumeric></td><td><ix:nonnumeric>The Nasdaq Stock Market LLC</ix:nonnumeric></td></tr><tr><td><ix:nonnumeric>1.375% Notes due 2029</ix:nonnumeric></td><td><ix:nonnumeric></ix:nonnumeric></td><td><ix:nonnumeric>The Nasdaq Stock Market LLC</ix:nonnumeric></td></tr><tr><td><ix:nonnumeric>3.050% Notes due 2029</ix:nonnumeric></td><td><ix:nonnumeric></ix:nonnumeric></td><td><ix:nonnumeric>The Nasdaq Stock Market LLC</ix:nonnumeric></td></tr><tr><td><ix:nonnumeric>0.500% Notes due 2031</ix:nonnumeric></td><td><ix:nonnumeric></ix:nonnumeric></td><td><ix:nonnumeric>The Nasdaq Stock Market LLC</ix:nonnumeric></td></tr><tr><td><ix:nonnumeric>3.600% Notes due 2042</ix:nonnumeric></td><td><ix:nonnumeric></ix:nonnumeric></td><td><ix:nonnumeric>The Nasdaq Stock Market LLC</ix:nonnumeric></td></tr></table></div><div>Indicate by check mark whether the Registrant (1)has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2)has been subject to such filing requirements for the past 90 days.</div><div><ix:nonnumeric>Yes</ix:nonnumeric>No</div><div>Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).</div><div><ix:nonnumeric>Yes</ix:nonnumeric>No</div><div>Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.</div><div><table><tr><td><ix:nonnumeric>Large accelerated filer</ix:nonnumeric></td><td></td><td>Accelerated filer</td><td></td></tr><tr><td>Non-accelerated filer</td><td></td><td>Smaller reporting company</td><td><ix:nonnumeric></ix:nonnumeric></td></tr><tr><td>Emerging growth company</td><td><ix:nonnumeric></ix:nonnumeric></td></tr></table></div><div>If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </div><div>Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</div><div>Yes<ix:nonnumeric></ix:nonnumeric>No</div><div><ix:nonfraction>14,840,390,000</ix:nonfraction> shares of common stock were issued and outstanding as of July18, 2025.</div><div><div><div><br/></div></div></div><hr/><div><div><br/></div></div><div>Apple Inc.</div><div><br/></div><div>Form 10-Q</div><div>For the Fiscal Quarter Ended June28, 2025 </div><div>TABLE OF CONTENTS</div><div><br/></div><div><table><tr><td>Page</td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_10">Part I</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_13">Item 1.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_13">Financial Statements</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_13">1</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_67">Item 2.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_67">Managements Discussion and Analysis of Financial Condition and Results of Operations</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_67">13</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_148">Item 3.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_148">Quantitative and Qualitative Disclosures About Market Risk</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_148">19</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_151">Item 4.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_151">Controls and Procedures</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_151">19</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_154">Part II</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_157">Item 1.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_157">Legal Proceedings</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_157">20</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_160">Item 1A.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_160">Risk Factors</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_160">21</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_163">Item 2.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_163">Unregistered Sales of Equity Securities and Use of Proceeds</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_163">21</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_166">Item 3.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_166">Defaults Upon Senior Securities</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_166">21</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_169">Item 4.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_169">Mine Safety Disclosures</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_169">21</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_172">Item 5.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_172">Other Information</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_172">21</a></div></td></tr><tr><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_178">Item 6.</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_178">Exhibits</a></div></td><td><div><a href="#i47143780af9f4d3d85123ce19d9f33bd_178">22</a></div></td></tr></table></div><div><div><div><br/></div></div></div><hr/><div><div><br/></div></div><div>PART I  FINANCIAL INFORMATION</div><div>Item 1.Financial Statements</div><div>Apple Inc.</div><div>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</div><div>(In millions, except number of shares, which are reflected in thousands, and per-share amounts)</div><div><br/></div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Net sales:</td></tr><tr><td>Products</td><td>$</td><td><ix:nonfraction>66,613</ix:nonfraction></td><td>$</td><td><ix:nonfraction>61,564</ix:nonfraction></td><td>$</td><td><ix:nonfraction>233,287</ix:nonfraction></td><td>$</td><td><ix:nonfraction>224,908</ix:nonfraction></td></tr><tr><td>Services</td><td><ix:nonfraction>27,423</ix:nonfraction></td><td><ix:nonfraction>24,213</ix:nonfraction></td><td><ix:nonfraction>80,408</ix:nonfraction></td><td><ix:nonfraction>71,197</ix:nonfraction></td></tr><tr><td>Total net sales</td><td><ix:nonfraction>94,036</ix:nonfraction></td><td><ix:nonfraction>85,777</ix:nonfraction></td><td><ix:nonfraction>313,695</ix:nonfraction></td><td><ix:nonfraction>296,105</ix:nonfraction></td></tr><tr><td>Cost of sales:</td></tr><tr><td>Products</td><td><ix:nonfraction>43,620</ix:nonfraction></td><td><ix:nonfraction>39,803</ix:nonfraction></td><td><ix:nonfraction>147,097</ix:nonfraction></td><td><ix:nonfraction>140,667</ix:nonfraction></td></tr><tr><td>Services</td><td><ix:nonfraction>6,698</ix:nonfraction></td><td><ix:nonfraction>6,296</ix:nonfraction></td><td><ix:nonfraction>19,738</ix:nonfraction></td><td><ix:nonfraction>18,634</ix:nonfraction></td></tr><tr><td>Total cost of sales</td><td><ix:nonfraction>50,318</ix:nonfraction></td><td><ix:nonfraction>46,099</ix:nonfraction></td><td><ix:nonfraction>166,835</ix:nonfraction></td><td><ix:nonfraction>159,301</ix:nonfraction></td></tr><tr><td>Gross margin</td><td><ix:nonfraction>43,718</ix:nonfraction></td><td><ix:nonfraction>39,678</ix:nonfraction></td><td><ix:nonfraction>146,860</ix:nonfraction></td><td><ix:nonfraction>136,804</ix:nonfraction></td></tr><tr><td>Operating expenses:</td></tr><tr><td>Research and development</td><td><ix:nonfraction>8,866</ix:nonfraction></td><td><ix:nonfraction>8,006</ix:nonfraction></td><td><ix:nonfraction>25,684</ix:nonfraction></td><td><ix:nonfraction>23,605</ix:nonfraction></td></tr><tr><td>Selling, general and administrative</td><td><ix:nonfraction>6,650</ix:nonfraction></td><td><ix:nonfraction>6,320</ix:nonfraction></td><td><ix:nonfraction>20,553</ix:nonfraction></td><td><ix:nonfraction>19,574</ix:nonfraction></td></tr><tr><td>Total operating expenses</td><td><ix:nonfraction>15,516</ix:nonfraction></td><td><ix:nonfraction>14,326</ix:nonfraction></td><td><ix:nonfraction>46,237</ix:nonfraction></td><td><ix:nonfraction>43,179</ix:nonfraction></td></tr><tr><td>Operating income</td><td><ix:nonfraction>28,202</ix:nonfraction></td><td><ix:nonfraction>25,352</ix:nonfraction></td><td><ix:nonfraction>100,623</ix:nonfraction></td><td><ix:nonfraction>93,625</ix:nonfraction></td></tr><tr><td>Other income/(expense), net</td><td>(<ix:nonfraction>171</ix:nonfraction>)</td><td><ix:nonfraction>142</ix:nonfraction></td><td>(<ix:nonfraction>698</ix:nonfraction>)</td><td><ix:nonfraction>250</ix:nonfraction></td></tr><tr><td>Income before provision for income taxes</td><td><ix:nonfraction>28,031</ix:nonfraction></td><td><ix:nonfraction>25,494</ix:nonfraction></td><td><ix:nonfraction>99,925</ix:nonfraction></td><td><ix:nonfraction>93,875</ix:nonfraction></td></tr><tr><td>Provision for income taxes</td><td><ix:nonfraction>4,597</ix:nonfraction></td><td><ix:nonfraction>4,046</ix:nonfraction></td><td><ix:nonfraction>15,381</ix:nonfraction></td><td><ix:nonfraction>14,875</ix:nonfraction></td></tr><tr><td>Net income</td><td>$</td><td><ix:nonfraction>23,434</ix:nonfraction></td><td>$</td><td><ix:nonfraction>21,448</ix:nonfraction></td><td>$</td><td><ix:nonfraction>84,544</ix:nonfraction></td><td>$</td><td><ix:nonfraction>79,000</ix:nonfraction></td></tr><tr><td>Earnings per share:</td></tr><tr><td>Basic</td><td>$</td><td><ix:nonfraction>1.57</ix:nonfraction></td><td>$</td><td><ix:nonfraction>1.40</ix:nonfraction></td><td>$</td><td><ix:nonfraction>5.64</ix:nonfraction></td><td>$</td><td><ix:nonfraction>5.13</ix:nonfraction></td></tr><tr><td>Diluted</td><td>$</td><td><ix:nonfraction>1.57</ix:nonfraction></td><td>$</td><td><ix:nonfraction>1.40</ix:nonfraction></td><td>$</td><td><ix:nonfraction>5.62</ix:nonfraction></td><td>$</td><td><ix:nonfraction>5.11</ix:nonfraction></td></tr><tr><td>Shares used in computing earnings per share:</td></tr><tr><td>Basic</td><td><ix:nonfraction>14,902,886</ix:nonfraction></td><td><ix:nonfraction>15,287,521</ix:nonfraction></td><td><ix:nonfraction>14,992,898</ix:nonfraction></td><td><ix:nonfraction>15,401,047</ix:nonfraction></td></tr><tr><td>Diluted</td><td><ix:nonfraction>14,948,179</ix:nonfraction></td><td><ix:nonfraction>15,348,175</ix:nonfraction></td><td><ix:nonfraction>15,051,726</ix:nonfraction></td><td><ix:nonfraction>15,463,175</ix:nonfraction></td></tr></table></div><div>See accompanying Notes to Condensed Consolidated Financial Statements.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 1</div></div></div><hr/><div><div><br/></div></div><div>Apple Inc.</div><div>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)</div><div>(In millions)</div><div><br/></div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Net income</td><td>$</td><td><ix:nonfraction>23,434</ix:nonfraction></td><td>$</td><td><ix:nonfraction>21,448</ix:nonfraction></td><td>$</td><td><ix:nonfraction>84,544</ix:nonfraction></td><td>$</td><td><ix:nonfraction>79,000</ix:nonfraction></td></tr><tr><td>Other comprehensive income/(loss):</td></tr><tr><td>Change in foreign currency translation, net of tax</td><td><ix:nonfraction>449</ix:nonfraction></td><td>(<ix:nonfraction>73</ix:nonfraction>)</td><td>(<ix:nonfraction>86</ix:nonfraction>)</td><td>(<ix:nonfraction>87</ix:nonfraction>)</td></tr><tr><td>Change in unrealized gains/losses on derivative instruments, net of tax:</td></tr><tr><td>Change in fair value of derivative instruments</td><td>(<ix:nonfraction>523</ix:nonfraction>)</td><td><ix:nonfraction>406</ix:nonfraction></td><td><ix:nonfraction>810</ix:nonfraction></td><td><ix:nonfraction>331</ix:nonfraction></td></tr><tr><td>Adjustment for net (gains)/losses realized and included in net income</td><td>(<ix:nonfraction>571</ix:nonfraction>)</td><td>(<ix:nonfraction>87</ix:nonfraction>)</td><td>(<ix:nonfraction>415</ix:nonfraction>)</td><td>(<ix:nonfraction>678</ix:nonfraction>)</td></tr><tr><td>Total change in unrealized gains/losses on derivative instruments</td><td>(<ix:nonfraction>1,094</ix:nonfraction>)</td><td><ix:nonfraction>319</ix:nonfraction></td><td><ix:nonfraction>395</ix:nonfraction></td><td>(<ix:nonfraction>347</ix:nonfraction>)</td></tr><tr><td>Change in unrealized gains/losses on marketable debt securities, net of tax:</td></tr><tr><td>Change in fair value of marketable debt securities</td><td><ix:nonfraction>640</ix:nonfraction></td><td><ix:nonfraction>268</ix:nonfraction></td><td><ix:nonfraction>90</ix:nonfraction></td><td><ix:nonfraction>3,306</ix:nonfraction></td></tr><tr><td>Adjustment for net (gains)/losses realized and included in net income</td><td>(<ix:nonfraction>1</ix:nonfraction>)</td><td><ix:nonfraction>30</ix:nonfraction></td><td><ix:nonfraction>404</ix:nonfraction></td><td><ix:nonfraction>164</ix:nonfraction></td></tr><tr><td>Total change in unrealized gains/losses on marketable debt securities</td><td><ix:nonfraction>639</ix:nonfraction></td><td><ix:nonfraction>298</ix:nonfraction></td><td><ix:nonfraction>494</ix:nonfraction></td><td><ix:nonfraction>3,470</ix:nonfraction></td></tr><tr><td>Total other comprehensive income/(loss)</td><td>(<ix:nonfraction>6</ix:nonfraction>)</td><td><ix:nonfraction>544</ix:nonfraction></td><td><ix:nonfraction>803</ix:nonfraction></td><td><ix:nonfraction>3,036</ix:nonfraction></td></tr><tr><td>Total comprehensive income</td><td>$</td><td><ix:nonfraction>23,428</ix:nonfraction></td><td>$</td><td><ix:nonfraction>21,992</ix:nonfraction></td><td>$</td><td><ix:nonfraction>85,347</ix:nonfraction></td><td>$</td><td><ix:nonfraction>82,036</ix:nonfraction></td></tr></table></div><div>See accompanying Notes to Condensed Consolidated Financial Statements.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 2</div></div></div><hr/><div><div><br/></div></div><div>Apple Inc.</div><div>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</div><div>(In millions, except number of shares, which are reflected in thousands, and par value)</div><div><br/></div><div><table><tr><td>June 28,<br/>2025</td><td>September 28,<br/>2024</td></tr><tr><td>ASSETS:</td></tr><tr><td>Current assets:</td></tr><tr><td>Cash and cash equivalents</td><td>$</td><td><ix:nonfraction>36,269</ix:nonfraction></td><td>$</td><td><ix:nonfraction>29,943</ix:nonfraction></td></tr><tr><td>Marketable securities</td><td><ix:nonfraction>19,103</ix:nonfraction></td><td><ix:nonfraction>35,228</ix:nonfraction></td></tr><tr><td>Accounts receivable, net</td><td><ix:nonfraction>27,557</ix:nonfraction></td><td><ix:nonfraction>33,410</ix:nonfraction></td></tr><tr><td>Vendor non-trade receivables</td><td><ix:nonfraction>19,278</ix:nonfraction></td><td><ix:nonfraction>32,833</ix:nonfraction></td></tr><tr><td>Inventories</td><td><ix:nonfraction>5,925</ix:nonfraction></td><td><ix:nonfraction>7,286</ix:nonfraction></td></tr><tr><td>Other current assets</td><td><ix:nonfraction>14,359</ix:nonfraction></td><td><ix:nonfraction>14,287</ix:nonfraction></td></tr><tr><td>Total current assets</td><td><ix:nonfraction>122,491</ix:nonfraction></td><td><ix:nonfraction>152,987</ix:nonfraction></td></tr><tr><td>Non-current assets:</td></tr><tr><td>Marketable securities</td><td><ix:nonfraction>77,614</ix:nonfraction></td><td><ix:nonfraction>91,479</ix:nonfraction></td></tr><tr><td>Property, plant and equipment, net</td><td><ix:nonfraction>48,508</ix:nonfraction></td><td><ix:nonfraction>45,680</ix:nonfraction></td></tr><tr><td>Other non-current assets</td><td><ix:nonfraction>82,882</ix:nonfraction></td><td><ix:nonfraction>74,834</ix:nonfraction></td></tr><tr><td>Total non-current assets</td><td><ix:nonfraction>209,004</ix:nonfraction></td><td><ix:nonfraction>211,993</ix:nonfraction></td></tr><tr><td>Total assets</td><td>$</td><td><ix:nonfraction>331,495</ix:nonfraction></td><td>$</td><td><ix:nonfraction>364,980</ix:nonfraction></td></tr><tr><td>LIABILITIES AND SHAREHOLDERS EQUITY:</td></tr><tr><td>Current liabilities:</td></tr><tr><td>Accounts payable</td><td>$</td><td><ix:nonfraction>50,374</ix:nonfraction></td><td>$</td><td><ix:nonfraction>68,960</ix:nonfraction></td></tr><tr><td>Other current liabilities</td><td><ix:nonfraction>62,499</ix:nonfraction></td><td><ix:nonfraction>78,304</ix:nonfraction></td></tr><tr><td>Deferred revenue</td><td><ix:nonfraction>8,979</ix:nonfraction></td><td><ix:nonfraction>8,249</ix:nonfraction></td></tr><tr><td>Commercial paper</td><td><ix:nonfraction>9,923</ix:nonfraction></td><td><ix:nonfraction>9,967</ix:nonfraction></td></tr><tr><td>Term debt</td><td><ix:nonfraction>9,345</ix:nonfraction></td><td><ix:nonfraction>10,912</ix:nonfraction></td></tr><tr><td>Total current liabilities</td><td><ix:nonfraction>141,120</ix:nonfraction></td><td><ix:nonfraction>176,392</ix:nonfraction></td></tr><tr><td>Non-current liabilities:</td></tr><tr><td>Term debt</td><td><ix:nonfraction>82,430</ix:nonfraction></td><td><ix:nonfraction>85,750</ix:nonfraction></td></tr><tr><td>Other non-current liabilities</td><td><ix:nonfraction>42,115</ix:nonfraction></td><td><ix:nonfraction>45,888</ix:nonfraction></td></tr><tr><td>Total non-current liabilities</td><td><ix:nonfraction>124,545</ix:nonfraction></td><td><ix:nonfraction>131,638</ix:nonfraction></td></tr><tr><td>Total liabilities</td><td><ix:nonfraction>265,665</ix:nonfraction></td><td><ix:nonfraction>308,030</ix:nonfraction></td></tr><tr><td>Commitments and contingencies</td></tr><tr><td>Shareholders equity:</td></tr><tr><td><div>Common stock and additional paid-in capital, $<ix:nonfraction><ix:nonfraction>0.00001</ix:nonfraction></ix:nonfraction> par value: <ix:nonfraction><ix:nonfraction>50,400,000</ix:nonfraction></ix:nonfraction> shares authorized; <ix:nonfraction><ix:nonfraction>14,856,722</ix:nonfraction></ix:nonfraction> and <ix:nonfraction><ix:nonfraction>15,116,786</ix:nonfraction></ix:nonfraction> shares issued and outstanding, respectively</div></td><td><ix:nonfraction>89,806</ix:nonfraction></td><td><ix:nonfraction>83,276</ix:nonfraction></td></tr><tr><td>Accumulated deficit</td><td>(<ix:nonfraction>17,607</ix:nonfraction>)</td><td>(<ix:nonfraction>19,154</ix:nonfraction>)</td></tr><tr><td>Accumulated other comprehensive loss</td><td>(<ix:nonfraction>6,369</ix:nonfraction>)</td><td>(<ix:nonfraction>7,172</ix:nonfraction>)</td></tr><tr><td>Total shareholders equity</td><td><ix:nonfraction>65,830</ix:nonfraction></td><td><ix:nonfraction>56,950</ix:nonfraction></td></tr><tr><td>Total liabilities and shareholders equity</td><td>$</td><td><ix:nonfraction>331,495</ix:nonfraction></td><td>$</td><td><ix:nonfraction>364,980</ix:nonfraction></td></tr></table></div><div>See accompanying Notes to Condensed Consolidated Financial Statements.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 3</div></div></div><hr/><div><div><br/></div></div><div>Apple Inc.</div><div>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited)</div><div>(In millions, except per-share amounts)</div><div><br/></div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Total shareholders equity, beginning balances</td><td>$</td><td><ix:nonfraction>66,796</ix:nonfraction></td><td>$</td><td><ix:nonfraction>74,194</ix:nonfraction></td><td>$</td><td><ix:nonfraction>56,950</ix:nonfraction></td><td>$</td><td><ix:nonfraction>62,146</ix:nonfraction></td></tr><tr><td>Common stock and additional paid-in capital:</td></tr><tr><td>Beginning balances</td><td><ix:nonfraction>88,711</ix:nonfraction></td><td><ix:nonfraction>78,815</ix:nonfraction></td><td><ix:nonfraction>83,276</ix:nonfraction></td><td><ix:nonfraction>73,812</ix:nonfraction></td></tr><tr><td>Common stock issued</td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>825</ix:nonfraction></td><td><ix:nonfraction>752</ix:nonfraction></td></tr><tr><td>Common stock withheld related to net share settlement of equity awards</td><td>(<ix:nonfraction>2,163</ix:nonfraction>)</td><td>(<ix:nonfraction>1,920</ix:nonfraction>)</td><td>(<ix:nonfraction>4,260</ix:nonfraction>)</td><td>(<ix:nonfraction>3,802</ix:nonfraction>)</td></tr><tr><td>Share-based compensation</td><td><ix:nonfraction>3,258</ix:nonfraction></td><td><ix:nonfraction>2,955</ix:nonfraction></td><td><ix:nonfraction>9,965</ix:nonfraction></td><td><ix:nonfraction>9,088</ix:nonfraction></td></tr><tr><td>Ending balances</td><td><ix:nonfraction>89,806</ix:nonfraction></td><td><ix:nonfraction>79,850</ix:nonfraction></td><td><ix:nonfraction>89,806</ix:nonfraction></td><td><ix:nonfraction>79,850</ix:nonfraction></td></tr><tr><td>Retained earnings/(Accumulated deficit):</td></tr><tr><td>Beginning balances</td><td>(<ix:nonfraction>15,552</ix:nonfraction>)</td><td><ix:nonfraction>4,339</ix:nonfraction></td><td>(<ix:nonfraction>19,154</ix:nonfraction>)</td><td>(<ix:nonfraction>214</ix:nonfraction>)</td></tr><tr><td>Net income</td><td><ix:nonfraction>23,434</ix:nonfraction></td><td><ix:nonfraction>21,448</ix:nonfraction></td><td><ix:nonfraction>84,544</ix:nonfraction></td><td><ix:nonfraction>79,000</ix:nonfraction></td></tr><tr><td>Dividends and dividend equivalents declared</td><td>(<ix:nonfraction>3,912</ix:nonfraction>)</td><td>(<ix:nonfraction>3,864</ix:nonfraction>)</td><td>(<ix:nonfraction>11,525</ix:nonfraction>)</td><td>(<ix:nonfraction>11,384</ix:nonfraction>)</td></tr><tr><td>Common stock withheld related to net share settlement of equity awards</td><td>(<ix:nonfraction>411</ix:nonfraction>)</td><td>(<ix:nonfraction>428</ix:nonfraction>)</td><td>(<ix:nonfraction>1,598</ix:nonfraction>)</td><td>(<ix:nonfraction>1,517</ix:nonfraction>)</td></tr><tr><td>Common stock repurchased</td><td>(<ix:nonfraction>21,166</ix:nonfraction>)</td><td>(<ix:nonfraction>26,221</ix:nonfraction>)</td><td>(<ix:nonfraction>69,874</ix:nonfraction>)</td><td>(<ix:nonfraction>70,611</ix:nonfraction>)</td></tr><tr><td>Ending balances</td><td>(<ix:nonfraction>17,607</ix:nonfraction>)</td><td>(<ix:nonfraction>4,726</ix:nonfraction>)</td><td>(<ix:nonfraction>17,607</ix:nonfraction>)</td><td>(<ix:nonfraction>4,726</ix:nonfraction>)</td></tr><tr><td>Accumulated other comprehensive loss:</td></tr><tr><td>Beginning balances</td><td>(<ix:nonfraction>6,363</ix:nonfraction>)</td><td>(<ix:nonfraction>8,960</ix:nonfraction>)</td><td>(<ix:nonfraction>7,172</ix:nonfraction>)</td><td>(<ix:nonfraction>11,452</ix:nonfraction>)</td></tr><tr><td>Other comprehensive income/(loss)</td><td>(<ix:nonfraction>6</ix:nonfraction>)</td><td><ix:nonfraction>544</ix:nonfraction></td><td><ix:nonfraction>803</ix:nonfraction></td><td><ix:nonfraction>3,036</ix:nonfraction></td></tr><tr><td>Ending balances</td><td>(<ix:nonfraction>6,369</ix:nonfraction>)</td><td>(<ix:nonfraction>8,416</ix:nonfraction>)</td><td>(<ix:nonfraction>6,369</ix:nonfraction>)</td><td>(<ix:nonfraction>8,416</ix:nonfraction>)</td></tr><tr><td>Total shareholders equity, ending balances</td><td>$</td><td><ix:nonfraction>65,830</ix:nonfraction></td><td>$</td><td><ix:nonfraction>66,708</ix:nonfraction></td><td>$</td><td><ix:nonfraction>65,830</ix:nonfraction></td><td>$</td><td><ix:nonfraction>66,708</ix:nonfraction></td></tr><tr><td>Dividends and dividend equivalents declared per share or RSU</td><td>$</td><td><ix:nonfraction>0.26</ix:nonfraction></td><td>$</td><td><ix:nonfraction>0.25</ix:nonfraction></td><td>$</td><td><ix:nonfraction>0.76</ix:nonfraction></td><td>$</td><td><ix:nonfraction>0.73</ix:nonfraction></td></tr></table></div><div>See accompanying Notes to Condensed Consolidated Financial Statements.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 4</div></div></div><hr/><div><div><br/></div></div><div>Apple Inc.</div><div>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</div><div>(In millions)</div><div><br/></div><div><table><tr><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td><div>Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances</div></td><td>$</td><td><ix:nonfraction>29,943</ix:nonfraction></td><td>$</td><td><ix:nonfraction>30,737</ix:nonfraction></td></tr><tr><td>Operating activities:</td></tr><tr><td>Net income</td><td><ix:nonfraction>84,544</ix:nonfraction></td><td><ix:nonfraction>79,000</ix:nonfraction></td></tr><tr><td>Adjustments to reconcile net income to cash generated by operating activities:</td></tr><tr><td>Depreciation and amortization</td><td><ix:nonfraction>8,571</ix:nonfraction></td><td><ix:nonfraction>8,534</ix:nonfraction></td></tr><tr><td>Share-based compensation expense</td><td><ix:nonfraction>9,680</ix:nonfraction></td><td><ix:nonfraction>8,830</ix:nonfraction></td></tr><tr><td>Other</td><td>(<ix:nonfraction>1,748</ix:nonfraction>)</td><td>(<ix:nonfraction>1,964</ix:nonfraction>)</td></tr><tr><td>Changes in operating assets and liabilities:</td></tr><tr><td>Accounts receivable, net</td><td><ix:nonfraction>5,685</ix:nonfraction></td><td><ix:nonfraction>6,697</ix:nonfraction></td></tr><tr><td>Vendor non-trade receivables</td><td><ix:nonfraction>13,555</ix:nonfraction></td><td><ix:nonfraction>11,100</ix:nonfraction></td></tr><tr><td>Inventories</td><td><ix:nonfraction>1,223</ix:nonfraction></td><td><ix:nonfraction>41</ix:nonfraction></td></tr><tr><td>Other current and non-current assets</td><td>(<ix:nonfraction>6,116</ix:nonfraction>)</td><td>(<ix:nonfraction>5,626</ix:nonfraction>)</td></tr><tr><td>Accounts payable</td><td>(<ix:nonfraction>18,479</ix:nonfraction>)</td><td>(<ix:nonfraction>15,171</ix:nonfraction>)</td></tr><tr><td>Other current and non-current liabilities</td><td>(<ix:nonfraction>15,161</ix:nonfraction>)</td><td><ix:nonfraction>2</ix:nonfraction></td></tr><tr><td>Cash generated by operating activities</td><td><ix:nonfraction>81,754</ix:nonfraction></td><td><ix:nonfraction>91,443</ix:nonfraction></td></tr><tr><td>Investing activities:</td></tr><tr><td>Purchases of marketable securities</td><td>(<ix:nonfraction>17,591</ix:nonfraction>)</td><td>(<ix:nonfraction>38,074</ix:nonfraction>)</td></tr><tr><td>Proceeds from maturities of marketable securities</td><td><ix:nonfraction>35,036</ix:nonfraction></td><td><ix:nonfraction>39,838</ix:nonfraction></td></tr><tr><td>Proceeds from sales of marketable securities</td><td><ix:nonfraction>10,785</ix:nonfraction></td><td><ix:nonfraction>7,382</ix:nonfraction></td></tr><tr><td>Payments for acquisition of property, plant and equipment</td><td>(<ix:nonfraction>9,473</ix:nonfraction>)</td><td>(<ix:nonfraction>6,539</ix:nonfraction>)</td></tr><tr><td>Other</td><td>(<ix:nonfraction>975</ix:nonfraction>)</td><td>(<ix:nonfraction>1,117</ix:nonfraction>)</td></tr><tr><td>Cash generated by investing activities</td><td><ix:nonfraction>17,782</ix:nonfraction></td><td><ix:nonfraction>1,490</ix:nonfraction></td></tr><tr><td>Financing activities:</td></tr><tr><td>Payments for taxes related to net share settlement of equity awards</td><td>(<ix:nonfraction>5,719</ix:nonfraction>)</td><td>(<ix:nonfraction>5,163</ix:nonfraction>)</td></tr><tr><td>Payments for dividends and dividend equivalents</td><td>(<ix:nonfraction>11,559</ix:nonfraction>)</td><td>(<ix:nonfraction>11,430</ix:nonfraction>)</td></tr><tr><td>Repurchases of common stock</td><td>(<ix:nonfraction>70,579</ix:nonfraction>)</td><td>(<ix:nonfraction>69,866</ix:nonfraction>)</td></tr><tr><td>Proceeds from issuance of term debt, net</td><td><ix:nonfraction>4,481</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td></tr><tr><td>Repayments of term debt</td><td>(<ix:nonfraction>9,682</ix:nonfraction>)</td><td>(<ix:nonfraction>7,400</ix:nonfraction>)</td></tr><tr><td>Repayments of commercial paper, net</td><td>(<ix:nonfraction>65</ix:nonfraction>)</td><td>(<ix:nonfraction>2,985</ix:nonfraction>)</td></tr><tr><td>Other</td><td>(<ix:nonfraction>87</ix:nonfraction>)</td><td>(<ix:nonfraction>191</ix:nonfraction>)</td></tr><tr><td>Cash used in financing activities</td><td>(<ix:nonfraction>93,210</ix:nonfraction>)</td><td>(<ix:nonfraction>97,035</ix:nonfraction>)</td></tr><tr><td>Increase/(Decrease) in cash, cash equivalents, and restricted cash and cash equivalents</td><td><ix:nonfraction>6,326</ix:nonfraction></td><td>(<ix:nonfraction>4,102</ix:nonfraction>)</td></tr><tr><td><div>Cash, cash equivalents, and restricted cash and cash equivalents, ending balances</div></td><td>$</td><td><ix:nonfraction>36,269</ix:nonfraction></td><td>$</td><td><ix:nonfraction>26,635</ix:nonfraction></td></tr><tr><td>Supplemental cash flow disclosure:</td></tr><tr><td>Cash paid for income taxes, net</td><td>$</td><td><ix:nonfraction>37,332</ix:nonfraction></td><td>$</td><td><ix:nonfraction>19,230</ix:nonfraction></td></tr></table></div><div>See accompanying Notes to Condensed Consolidated Financial Statements.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 5</div></div></div><hr/><div><div><br/></div></div><div>Apple Inc.</div><div>Notes to Condensed Consolidated Financial Statements (Unaudited)</div><div>Note 1  <ix:nonnumeric>Summary of Significant Accounting Policies</ix:nonnumeric></div><ix:continuation><ix:nonnumeric><div>Basis of Presentation and Preparation</div><div>The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively Apple or the Company). In the opinion of the Companys management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (GAAP) requires the use of management estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Companys annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September28, 2024 (the 2024 Form 10-K).</div></ix:nonnumeric><ix:nonnumeric><div>The Companys fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Companys fiscal quarters with calendar quarters. The Companys fiscal years 2025 and 2024 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Companys fiscal years ended in September and the associated quarters, months and periods of those fiscal years.</div></ix:nonnumeric></ix:continuation><div>Note 2  <ix:nonnumeric>Revenue</ix:nonnumeric></div><ix:continuation><ix:nonnumeric><div>The following table shows disaggregated net sales, as well as the portion of total net sales that was previously deferred, for the three- and nine-month periods ended June 28, 2025 and June29, 2024 (in millions):</div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td><div>iPhone</div></td><td>$</td><td><ix:nonfraction>44,582</ix:nonfraction></td><td>$</td><td><ix:nonfraction>39,296</ix:nonfraction></td><td>$</td><td><ix:nonfraction>160,561</ix:nonfraction></td><td>$</td><td><ix:nonfraction>154,961</ix:nonfraction></td></tr><tr><td><div>Mac</div></td><td><ix:nonfraction>8,046</ix:nonfraction></td><td><ix:nonfraction>7,009</ix:nonfraction></td><td><ix:nonfraction>24,982</ix:nonfraction></td><td><ix:nonfraction>22,240</ix:nonfraction></td></tr><tr><td><div>iPad</div></td><td><ix:nonfraction>6,581</ix:nonfraction></td><td><ix:nonfraction>7,162</ix:nonfraction></td><td><ix:nonfraction>21,071</ix:nonfraction></td><td><ix:nonfraction>19,744</ix:nonfraction></td></tr><tr><td>Wearables, Home and Accessories</td><td><ix:nonfraction>7,404</ix:nonfraction></td><td><ix:nonfraction>8,097</ix:nonfraction></td><td><ix:nonfraction>26,673</ix:nonfraction></td><td><ix:nonfraction>27,963</ix:nonfraction></td></tr><tr><td>Services</td><td><ix:nonfraction>27,423</ix:nonfraction></td><td><ix:nonfraction>24,213</ix:nonfraction></td><td><ix:nonfraction>80,408</ix:nonfraction></td><td><ix:nonfraction>71,197</ix:nonfraction></td></tr><tr><td>Total net sales</td><td>$</td><td><ix:nonfraction>94,036</ix:nonfraction></td><td>$</td><td><ix:nonfraction>85,777</ix:nonfraction></td><td>$</td><td><ix:nonfraction>313,695</ix:nonfraction></td><td>$</td><td><ix:nonfraction>296,105</ix:nonfraction></td></tr><tr><td><div>Portion of total net sales that was included in deferred revenue as of the beginning of the period</div></td><td>$</td><td><ix:nonfraction>4,015</ix:nonfraction></td><td>$</td><td><ix:nonfraction>3,405</ix:nonfraction></td><td>$</td><td><ix:nonfraction>6,958</ix:nonfraction></td><td>$</td><td><ix:nonfraction>6,541</ix:nonfraction></td></tr></table></div></ix:nonnumeric><div>The Companys proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 10, Segment Information and Geographic Data for the three- and nine-month periods ended June 28, 2025 and June29, 2024, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales.</div><div>As of June28, 2025 and September28, 2024, the Company had total deferred revenue of $<ix:nonfraction>13.6</ix:nonfraction> billion and $<ix:nonfraction>12.8</ix:nonfraction>billion, respectively. As of June28, 2025, the Company expects <ix:nonfraction>66</ix:nonfraction>% of total deferred revenue to be realized in less than a year, <ix:nonfraction>23</ix:nonfraction>% within one-to-two years, <ix:nonfraction>9</ix:nonfraction>% within two-to-three years and <ix:nonfraction>2</ix:nonfraction>% in greater than three years.</div></ix:continuation><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 6</div></div></div><hr/><div><div><br/></div></div><div>Note 3  <ix:nonnumeric>Earnings Per Share</ix:nonnumeric></div><ix:nonnumeric><ix:continuation><div>The following table shows the computation of basic and diluted earnings per share for the three- and nine-month periods ended June 28, 2025 and June 29, 2024 (net income in millions and shares in thousands):</div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Numerator:</td></tr><tr><td>Net income</td><td>$</td><td><ix:nonfraction>23,434</ix:nonfraction></td><td>$</td><td><ix:nonfraction>21,448</ix:nonfraction></td><td>$</td><td><ix:nonfraction>84,544</ix:nonfraction></td><td>$</td><td><ix:nonfraction>79,000</ix:nonfraction></td></tr><tr><td>Denominator:</td></tr><tr><td>Weighted-average basic shares outstanding</td><td><ix:nonfraction>14,902,886</ix:nonfraction></td><td><ix:nonfraction>15,287,521</ix:nonfraction></td><td><ix:nonfraction>14,992,898</ix:nonfraction></td><td><ix:nonfraction>15,401,047</ix:nonfraction></td></tr><tr><td><div>Effect of dilutive share-based awards</div></td><td><ix:nonfraction>45,293</ix:nonfraction></td><td><ix:nonfraction>60,654</ix:nonfraction></td><td><ix:nonfraction>58,828</ix:nonfraction></td><td><ix:nonfraction>62,128</ix:nonfraction></td></tr><tr><td>Weighted-average diluted shares</td><td><ix:nonfraction>14,948,179</ix:nonfraction></td><td><ix:nonfraction>15,348,175</ix:nonfraction></td><td><ix:nonfraction>15,051,726</ix:nonfraction></td><td><ix:nonfraction>15,463,175</ix:nonfraction></td></tr><tr><td>Basic earnings per share</td><td>$</td><td><ix:nonfraction>1.57</ix:nonfraction></td><td>$</td><td><ix:nonfraction>1.40</ix:nonfraction></td><td>$</td><td><ix:nonfraction>5.64</ix:nonfraction></td><td>$</td><td><ix:nonfraction>5.13</ix:nonfraction></td></tr><tr><td>Diluted earnings per share</td><td>$</td><td><ix:nonfraction>1.57</ix:nonfraction></td><td>$</td><td><ix:nonfraction>1.40</ix:nonfraction></td><td>$</td><td><ix:nonfraction>5.62</ix:nonfraction></td><td>$</td><td><ix:nonfraction>5.11</ix:nonfraction></td></tr></table></div></ix:continuation></ix:nonnumeric><div>Note 4  <ix:nonnumeric>Financial Instruments</ix:nonnumeric></div><ix:continuation><div>Cash, Cash Equivalents and Marketable Securities</div><ix:nonnumeric><div>The following tables show the Companys cash, cash equivalents and marketable securities by significant investment category as of June28, 2025 and September28, 2024 (in millions):</div><div><table><tr><td>June 28, 2025</td></tr><tr><td>Adjusted<br/>Cost</td><td>Unrealized<br/>Gains</td><td>Unrealized<br/>Losses</td><td>Fair<br/>Value</td><td>Cash and<br/>Cash<br/>Equivalents</td><td>Current<br/>Marketable<br/>Securities</td><td><div>Non-Current<br/>Marketable<br/>Securities</div></td></tr><tr><td>Cash</td><td>$</td><td><ix:nonfraction>26,686</ix:nonfraction></td><td>$</td><td></td><td>$</td><td></td><td>$</td><td><ix:nonfraction>26,686</ix:nonfraction></td><td>$</td><td><ix:nonfraction>26,686</ix:nonfraction></td><td>$</td><td></td><td>$</td><td></td></tr><tr><td><div>Level 1: </div></td></tr><tr><td>Money market funds</td><td><ix:nonfraction>3,779</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>3,779</ix:nonfraction></td><td><ix:nonfraction>3,779</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td></tr><tr><td><div>Mutual funds</div></td><td><ix:nonfraction>646</ix:nonfraction></td><td><ix:nonfraction>134</ix:nonfraction></td><td>(<ix:nonfraction>3</ix:nonfraction>)</td><td><ix:nonfraction>777</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>777</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td></tr><tr><td>Subtotal</td><td><ix:nonfraction>4,425</ix:nonfraction></td><td><ix:nonfraction>134</ix:nonfraction></td><td>(<ix:nonfraction>3</ix:nonfraction>)</td><td><ix:nonfraction>4,556</ix:nonfraction></td><td><ix:nonfraction>3,779</ix:nonfraction></td><td><ix:nonfraction>777</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td></tr><tr><td><div>Level 2 (1):</div></td></tr><tr><td>U.S. Treasury securities</td><td><ix:nonfraction>15,775</ix:nonfraction></td><td><ix:nonfraction>46</ix:nonfraction></td><td>(<ix:nonfraction>362</ix:nonfraction>)</td><td><ix:nonfraction>15,459</ix:nonfraction></td><td><ix:nonfraction>1,030</ix:nonfraction></td><td><ix:nonfraction>3,649</ix:nonfraction></td><td><ix:nonfraction>10,780</ix:nonfraction></td></tr><tr><td>U.S. agency securities</td><td><ix:nonfraction>5,383</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td>(<ix:nonfraction>189</ix:nonfraction>)</td><td><ix:nonfraction>5,194</ix:nonfraction></td><td><ix:nonfraction>647</ix:nonfraction></td><td><ix:nonfraction>2,030</ix:nonfraction></td><td><ix:nonfraction>2,517</ix:nonfraction></td></tr><tr><td>Non-U.S. government securities</td><td><ix:nonfraction>6,756</ix:nonfraction></td><td><ix:nonfraction>43</ix:nonfraction></td><td>(<ix:nonfraction>567</ix:nonfraction>)</td><td><ix:nonfraction>6,232</ix:nonfraction></td><td><ix:nonfraction>297</ix:nonfraction></td><td><ix:nonfraction>795</ix:nonfraction></td><td><ix:nonfraction>5,140</ix:nonfraction></td></tr><tr><td>Certificates of deposit and time deposits</td><td><ix:nonfraction>3,177</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>3,177</ix:nonfraction></td><td><ix:nonfraction>3,113</ix:nonfraction></td><td><ix:nonfraction>51</ix:nonfraction></td><td><ix:nonfraction>13</ix:nonfraction></td></tr><tr><td>Commercial paper</td><td><ix:nonfraction>710</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>710</ix:nonfraction></td><td><ix:nonfraction>710</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td></tr><tr><td>Corporate debt securities</td><td><ix:nonfraction>49,671</ix:nonfraction></td><td><ix:nonfraction>212</ix:nonfraction></td><td>(<ix:nonfraction>1,251</ix:nonfraction>)</td><td><ix:nonfraction>48,632</ix:nonfraction></td><td><ix:nonfraction>7</ix:nonfraction></td><td><ix:nonfraction>11,576</ix:nonfraction></td><td><ix:nonfraction>37,049</ix:nonfraction></td></tr><tr><td>Municipal securities</td><td><ix:nonfraction>263</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td>(<ix:nonfraction>3</ix:nonfraction>)</td><td><ix:nonfraction>260</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>157</ix:nonfraction></td><td><ix:nonfraction>103</ix:nonfraction></td></tr><tr><td>Mortgage- and asset-backed securities</td><td><ix:nonfraction>23,424</ix:nonfraction></td><td><ix:nonfraction>90</ix:nonfraction></td><td>(<ix:nonfraction>1,434</ix:nonfraction>)</td><td><ix:nonfraction>22,080</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>68</ix:nonfraction></td><td><ix:nonfraction>22,012</ix:nonfraction></td></tr><tr><td>Subtotal</td><td><ix:nonfraction>105,159</ix:nonfraction></td><td><ix:nonfraction>391</ix:nonfraction></td><td>(<ix:nonfraction>3,806</ix:nonfraction>)</td><td><ix:nonfraction>101,744</ix:nonfraction></td><td><ix:nonfraction>5,804</ix:nonfraction></td><td><ix:nonfraction>18,326</ix:nonfraction></td><td><ix:nonfraction>77,614</ix:nonfraction></td></tr><tr><td><div>Total</div></td><td>$</td><td><ix:nonfraction>136,270</ix:nonfraction></td><td>$</td><td><ix:nonfraction>525</ix:nonfraction></td><td>$</td><td>(<ix:nonfraction>3,809</ix:nonfraction>)</td><td>$</td><td><ix:nonfraction>132,986</ix:nonfraction></td><td>$</td><td><ix:nonfraction>36,269</ix:nonfraction></td><td>$</td><td><ix:nonfraction>19,103</ix:nonfraction></td><td>$</td><td><ix:nonfraction>77,614</ix:nonfraction></td></tr></table></div></ix:nonnumeric></ix:continuation><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 7</div></div></div><hr/><div><div><br/></div></div><ix:continuation><ix:continuation><div><table><tr><td>September 28, 2024</td></tr><tr><td>Adjusted<br/>Cost</td><td>Unrealized<br/>Gains</td><td>Unrealized<br/>Losses</td><td>Fair<br/>Value</td><td>Cash and<br/>Cash<br/>Equivalents</td><td>Current<br/>Marketable<br/>Securities</td><td>Non-Current<br/>Marketable<br/>Securities</td></tr><tr><td>Cash</td><td>$</td><td><ix:nonfraction>27,199</ix:nonfraction></td><td>$</td><td></td><td>$</td><td></td><td>$</td><td><ix:nonfraction>27,199</ix:nonfraction></td><td>$</td><td><ix:nonfraction>27,199</ix:nonfraction></td><td>$</td><td></td><td>$</td><td></td></tr><tr><td><div>Level 1:</div></td></tr><tr><td>Money market funds</td><td><ix:nonfraction>778</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>778</ix:nonfraction></td><td><ix:nonfraction>778</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td></tr><tr><td><div>Mutual funds</div></td><td><ix:nonfraction>515</ix:nonfraction></td><td><ix:nonfraction>105</ix:nonfraction></td><td>(<ix:nonfraction>3</ix:nonfraction>)</td><td><ix:nonfraction>617</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>617</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td></tr><tr><td>Subtotal</td><td><ix:nonfraction>1,293</ix:nonfraction></td><td><ix:nonfraction>105</ix:nonfraction></td><td>(<ix:nonfraction>3</ix:nonfraction>)</td><td><ix:nonfraction>1,395</ix:nonfraction></td><td><ix:nonfraction>778</ix:nonfraction></td><td><ix:nonfraction>617</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td></tr><tr><td><div>Level 2 (1):</div></td></tr><tr><td>U.S. Treasury securities</td><td><ix:nonfraction>16,150</ix:nonfraction></td><td><ix:nonfraction>45</ix:nonfraction></td><td>(<ix:nonfraction>516</ix:nonfraction>)</td><td><ix:nonfraction>15,679</ix:nonfraction></td><td><ix:nonfraction>212</ix:nonfraction></td><td><ix:nonfraction>4,087</ix:nonfraction></td><td><ix:nonfraction>11,380</ix:nonfraction></td></tr><tr><td>U.S. agency securities</td><td><ix:nonfraction>5,431</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td>(<ix:nonfraction>272</ix:nonfraction>)</td><td><ix:nonfraction>5,159</ix:nonfraction></td><td><ix:nonfraction>155</ix:nonfraction></td><td><ix:nonfraction>703</ix:nonfraction></td><td><ix:nonfraction>4,301</ix:nonfraction></td></tr><tr><td>Non-U.S. government securities</td><td><ix:nonfraction>17,959</ix:nonfraction></td><td><ix:nonfraction>93</ix:nonfraction></td><td>(<ix:nonfraction>484</ix:nonfraction>)</td><td><ix:nonfraction>17,568</ix:nonfraction></td><td><ix:nonfraction>1,158</ix:nonfraction></td><td><ix:nonfraction>10,810</ix:nonfraction></td><td><ix:nonfraction>5,600</ix:nonfraction></td></tr><tr><td>Certificates of deposit and time deposits</td><td><ix:nonfraction>873</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>873</ix:nonfraction></td><td><ix:nonfraction>387</ix:nonfraction></td><td><ix:nonfraction>478</ix:nonfraction></td><td><ix:nonfraction>8</ix:nonfraction></td></tr><tr><td>Commercial paper</td><td><ix:nonfraction>1,066</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>1,066</ix:nonfraction></td><td><ix:nonfraction>28</ix:nonfraction></td><td><ix:nonfraction>1,038</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td></tr><tr><td>Corporate debt securities</td><td><ix:nonfraction>65,622</ix:nonfraction></td><td><ix:nonfraction>270</ix:nonfraction></td><td>(<ix:nonfraction>1,953</ix:nonfraction>)</td><td><ix:nonfraction>63,939</ix:nonfraction></td><td><ix:nonfraction>26</ix:nonfraction></td><td><ix:nonfraction>16,027</ix:nonfraction></td><td><ix:nonfraction>47,886</ix:nonfraction></td></tr><tr><td>Municipal securities</td><td><ix:nonfraction>412</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td>(<ix:nonfraction>7</ix:nonfraction>)</td><td><ix:nonfraction>405</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>190</ix:nonfraction></td><td><ix:nonfraction>215</ix:nonfraction></td></tr><tr><td>Mortgage- and asset-backed securities</td><td><ix:nonfraction>24,595</ix:nonfraction></td><td><ix:nonfraction>175</ix:nonfraction></td><td>(<ix:nonfraction>1,403</ix:nonfraction>)</td><td><ix:nonfraction>23,367</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td><td><ix:nonfraction>1,278</ix:nonfraction></td><td><ix:nonfraction>22,089</ix:nonfraction></td></tr><tr><td>Subtotal</td><td><ix:nonfraction>132,108</ix:nonfraction></td><td><ix:nonfraction>583</ix:nonfraction></td><td>(<ix:nonfraction>4,635</ix:nonfraction>)</td><td><ix:nonfraction>128,056</ix:nonfraction></td><td><ix:nonfraction>1,966</ix:nonfraction></td><td><ix:nonfraction>34,611</ix:nonfraction></td><td><ix:nonfraction>91,479</ix:nonfraction></td></tr><tr><td><div>Total (2)(3)</div></td><td>$</td><td><ix:nonfraction>160,600</ix:nonfraction></td><td>$</td><td><ix:nonfraction>688</ix:nonfraction></td><td>$</td><td>(<ix:nonfraction>4,638</ix:nonfraction>)</td><td>$</td><td><ix:nonfraction>156,650</ix:nonfraction></td><td>$</td><td><ix:nonfraction>29,943</ix:nonfraction></td><td>$</td><td><ix:nonfraction>35,228</ix:nonfraction></td><td>$</td><td><ix:nonfraction>91,479</ix:nonfraction></td></tr></table></div><div>(1)<ix:nonnumeric>The valuation techniques used to measure the fair values of the Companys Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.</ix:nonnumeric></div><div>(2)As of September28, 2024, cash and cash equivalents included $<ix:nonfraction>2.6</ix:nonfraction>billion held in escrow and restricted from general use. These restricted cash and cash equivalents were designated to settle the Companys obligation related to the 2016 European Commission (the Commission) decision that Ireland granted state aid to the Company (the State Aid Decision), which was confirmed during the fourth quarter of 2024 by the European Court of Justice in a reversal of the 2020 judgment of the European General Court.</div><div>(3)As of September28, 2024, current marketable securities included $<ix:nonfraction>13.2</ix:nonfraction> billion held in escrow and restricted from general use. These restricted marketable securities were designated to settle the Companys obligation related to the State Aid Decision.</div></ix:continuation><div>As of June28, 2025, <ix:nonfraction>82</ix:nonfraction>% of the Companys non-current marketable debt securities other than mortgage- and asset-backed securities had maturities between 1 and 5 years, <ix:nonfraction>14</ix:nonfraction>% between 5 and 10 years, and <ix:nonfraction>4</ix:nonfraction>% greater than 10 years. As of June28, 2025, <ix:nonfraction>12</ix:nonfraction>% of the Companys non-current mortgage- and asset-backed securities had maturities between 1 and 5 years, <ix:nonfraction>11</ix:nonfraction>% between 5 and 10 years, and <ix:nonfraction>77</ix:nonfraction>% greater than 10 years.</div><div>Derivative Instruments and Hedging</div><div>The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates.</div><div>Foreign Exchange Rate Risk</div><div>To protect gross margins from fluctuations in foreign exchange rates, the Company may use forwards, options or other instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to <ix:nonnumeric>12</ix:nonnumeric> months.</div><div>To protect the Companys foreign currencydenominated term debt or marketable securities from fluctuations in foreign exchange rates, the Company may use forwards, cross-currency swaps or other instruments. The Company designates these instruments as either cash flow or fair value hedges. As of June28, 2025, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for term debtrelated foreign currency transactions is <ix:nonnumeric>17</ix:nonnumeric> years.</div><div>The Company may also use derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign exchange rates, as well as to offset a portion of the foreign currency gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.</div></ix:continuation><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 8</div></div></div><hr/><div><div><br/></div></div><ix:continuation><div>Interest Rate Risk</div><div>To protect the Companys term debt or marketable securities from fluctuations in interest rates, the Company may use interest rate swaps, options or other instruments. The Company designates these instruments as either cash flow or fair value hedges.</div><ix:nonnumeric><div>The notional amounts of the Companys outstanding derivative instruments as of June28, 2025 and September28, 2024, were as follows (in millions):</div><div><table><tr><td>June 28,<br/>2025</td><td>September 28,<br/>2024</td></tr><tr><td>Derivative instruments designated as accounting hedges:</td></tr><tr><td>Foreign exchange contracts</td><td>$</td><td><ix:nonfraction>63,212</ix:nonfraction></td><td>$</td><td><ix:nonfraction>64,069</ix:nonfraction></td></tr><tr><td>Interest rate contracts</td><td>$</td><td><ix:nonfraction>12,875</ix:nonfraction></td><td>$</td><td><ix:nonfraction>14,575</ix:nonfraction></td></tr><tr><td>Derivative instruments not designated as accounting hedges:</td></tr><tr><td>Foreign exchange contracts</td><td>$</td><td><ix:nonfraction>78,649</ix:nonfraction></td><td>$</td><td><ix:nonfraction>91,493</ix:nonfraction></td></tr></table></div></ix:nonnumeric><div>As of June28, 2025 and September28, 2024, the carrying amount of the Companys current and non-current term debt subject to fair value hedges was $<ix:nonfraction>12.5</ix:nonfraction> billion and $<ix:nonfraction>13.5</ix:nonfraction> billion, respectively.</div><div>Accounts Receivable</div><div>Trade Receivables</div><div>As of June28, 2025, the Company had <ix:nonfraction>two</ix:nonfraction> customers that individually represented 10% or more of total trade receivables, which accounted for <ix:nonfraction>18</ix:nonfraction>% and <ix:nonfraction>10</ix:nonfraction>%. The Companys third-party cellular network carriers accounted for <ix:nonfraction>31</ix:nonfraction>% and <ix:nonfraction>38</ix:nonfraction>% of total trade receivables as of June28, 2025 and September28, 2024, respectively. The Company requires third-party credit support or collateral from certain customers to limit credit risk.</div><div>Vendor Non-Trade Receivables</div><div>The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in products net sales. Rather, the Company recognizes any gain on these sales as a reduction of products cost of sales when the related final products are sold by the Company. As of June28, 2025, the Company had <ix:nonfraction>two</ix:nonfraction> vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for <ix:nonfraction>48</ix:nonfraction>% and <ix:nonfraction>14</ix:nonfraction>%. As of September28, 2024, the Company had <ix:nonfraction>two</ix:nonfraction> vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for <ix:nonfraction>44</ix:nonfraction>% and <ix:nonfraction>23</ix:nonfraction>%.</div></ix:continuation><div>Note 5  <ix:nonnumeric>Condensed Consolidated Financial Statement Details</ix:nonnumeric></div><ix:continuation><div>The following tables show the Companys condensed consolidated financial statement details as of June28, 2025 and September28, 2024 (in millions):</div><ix:nonnumeric><div>Inventories</div><div><table><tr><td>June 28,<br/>2025</td><td>September 28,<br/>2024</td></tr><tr><td><div>Components</div></td><td>$</td><td><ix:nonfraction>2,288</ix:nonfraction></td><td>$</td><td><ix:nonfraction>3,627</ix:nonfraction></td></tr><tr><td><div>Finished goods</div></td><td><ix:nonfraction>3,637</ix:nonfraction></td><td><ix:nonfraction>3,659</ix:nonfraction></td></tr><tr><td><div>Total inventories</div></td><td>$</td><td><ix:nonfraction>5,925</ix:nonfraction></td><td>$</td><td><ix:nonfraction>7,286</ix:nonfraction></td></tr></table></div></ix:nonnumeric><ix:nonnumeric><div>Property, Plant and Equipment, Net</div><div><table><tr><td>June 28,<br/>2025</td><td>September 28,<br/>2024</td></tr><tr><td>Gross property, plant and equipment</td><td>$</td><td><ix:nonfraction>124,311</ix:nonfraction></td><td>$</td><td><ix:nonfraction>119,128</ix:nonfraction></td></tr><tr><td><div>Accumulated depreciation</div></td><td>(<ix:nonfraction>75,803</ix:nonfraction>)</td><td>(<ix:nonfraction>73,448</ix:nonfraction>)</td></tr><tr><td>Total property, plant and equipment, net</td><td>$</td><td><ix:nonfraction>48,508</ix:nonfraction></td><td>$</td><td><ix:nonfraction>45,680</ix:nonfraction></td></tr></table></div></ix:nonnumeric></ix:continuation><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 9</div></div></div><hr/><div><div><br/></div></div><div>Note 6  <ix:nonnumeric>Debt</ix:nonnumeric></div><ix:continuation><div>Commercial Paper</div><div>The Company issues unsecured short-term promissory notes pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of June28, 2025 and September28, 2024, the Company had $<ix:nonfraction>9.9</ix:nonfraction> billion and $<ix:nonfraction>10.0</ix:nonfraction> billion of commercial paper outstanding, respectively. <ix:nonnumeric>The following table provides a summary of cash flows associated with commercial paper for the nine months ended June28, 2025 and June29, 2024 (in millions):</ix:nonnumeric></div><ix:continuation><div><table><tr><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Maturities 90 days or less:</td></tr><tr><td>Repayments of commercial paper, net</td><td>$</td><td>(<ix:nonfraction>5,690</ix:nonfraction>)</td><td>$</td><td>(<ix:nonfraction>2,985</ix:nonfraction>)</td></tr><tr><td>Maturities greater than 90 days:</td></tr><tr><td>Proceeds from commercial paper</td><td><ix:nonfraction>5,625</ix:nonfraction></td><td><ix:nonfraction></ix:nonfraction></td></tr><tr><td>Total repayments of commercial paper, net</td><td>$</td><td>(<ix:nonfraction>65</ix:nonfraction>)</td><td>$</td><td>(<ix:nonfraction>2,985</ix:nonfraction>)</td></tr></table></div></ix:continuation><div>Term Debt</div><div>As of June28, 2025 and September28, 2024, the Company had outstanding fixed-rate notes with varying maturities for an aggregate carrying amount of $<ix:nonfraction>91.8</ix:nonfraction> billion and $<ix:nonfraction>96.7</ix:nonfraction> billion, respectively (collectively the Notes). As of June28, 2025 and September28, 2024, the fair value of the Companys Notes, based on Level 2 inputs, was $<ix:nonfraction>80.4</ix:nonfraction> billion and $<ix:nonfraction>88.4</ix:nonfraction> billion, respectively.</div></ix:continuation><div>Note 7  <ix:nonnumeric>Shareholders Equity</ix:nonnumeric></div><ix:continuation><div>Share Repurchase Program</div><div>During the nine months ended June28, 2025, the Company repurchased <ix:nonfraction>312</ix:nonfraction> million shares of its common stock for $<ix:nonfraction>69.3</ix:nonfraction> billion. The Companys share repurchase programs do not obligate the Company to acquire a minimum amount of shares. Under the programs, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the Exchange Act).</div></ix:continuation><div>Note 8  <ix:nonnumeric>Share-Based Compensation</ix:nonnumeric></div><ix:continuation><div>Restricted Stock Units</div><ix:nonnumeric><div>A summary of the Companys RSU activity and related information for the nine months ended June28, 2025, is as follows:</div><div><table><tr><td><div>Number of</div><div>RSUs</div><div>(in thousands)</div></td><td>Weighted-Average<br/>Grant-Date Fair<br/>Value Per RSU</td></tr><tr><td>Balance as of September 28, 2024</td><td><ix:nonfraction>163,326</ix:nonfraction></td><td>$</td><td><ix:nonfraction>158.73</ix:nonfraction></td></tr><tr><td>RSUs granted</td><td><ix:nonfraction>66,667</ix:nonfraction></td><td>$</td><td><ix:nonfraction>226.87</ix:nonfraction></td></tr><tr><td>RSUs vested</td><td>(<ix:nonfraction>73,515</ix:nonfraction>)</td><td>$</td><td><ix:nonfraction>159.29</ix:nonfraction></td></tr><tr><td>RSUs canceled</td><td>(<ix:nonfraction>6,502</ix:nonfraction>)</td><td>$</td><td><ix:nonfraction>180.14</ix:nonfraction></td></tr><tr><td>Balance as of June 28, 2025</td><td><ix:nonfraction>149,976</ix:nonfraction></td><td>$</td><td><ix:nonfraction>187.82</ix:nonfraction></td></tr></table></div></ix:nonnumeric><div>The total vesting-date fair value of RSUs was $<ix:nonfraction>7.0</ix:nonfraction> billion and $<ix:nonfraction>16.3</ix:nonfraction> billion for the three- and nine-month periods ended June 28, 2025, respectively, and was $<ix:nonfraction>6.4</ix:nonfraction> billion and $<ix:nonfraction>15.0</ix:nonfraction> billion for the three- and nine-month periods ended June 29, 2024, respectively.</div></ix:continuation><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 10</div></div></div><hr/><div><div><br/></div></div><ix:continuation><div>Share-Based Compensation</div><ix:nonnumeric><div>The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 28, 2025 and June 29, 2024 (in millions):</div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Share-based compensation expense</td><td>$</td><td><ix:nonfraction>3,168</ix:nonfraction></td><td>$</td><td><ix:nonfraction>2,869</ix:nonfraction></td><td>$</td><td><ix:nonfraction>9,680</ix:nonfraction></td><td>$</td><td><ix:nonfraction>8,830</ix:nonfraction></td></tr><tr><td>Income tax benefit related to share-based compensation expense</td><td>$</td><td>(<ix:nonfraction>795</ix:nonfraction>)</td><td>$</td><td>(<ix:nonfraction>764</ix:nonfraction>)</td><td>$</td><td>(<ix:nonfraction>2,870</ix:nonfraction>)</td><td>$</td><td>(<ix:nonfraction>2,662</ix:nonfraction>)</td></tr></table></div></ix:nonnumeric><div>As of June28, 2025, the total unrecognized compensation cost related to outstanding RSUs was $<ix:nonfraction>23.7</ix:nonfraction> billion, which the Company expects to recognize over a weighted-average period of <ix:nonnumeric>2.6</ix:nonnumeric> years.</div></ix:continuation><div>Note 9  <ix:nonnumeric>Contingencies</ix:nonnumeric></div><ix:continuation><div>The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully resolved. The outcome of litigation is inherently uncertain. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.</div></ix:continuation><div>Note 10  <ix:nonnumeric>Segment Information and Geographic Data</ix:nonnumeric></div><ix:nonnumeric><ix:continuation><div>The following table shows information by reportable segment for the three- and nine-month periods ended June 28, 2025 and June 29, 2024 (in millions):</div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Americas:</td></tr><tr><td>Net sales</td><td>$</td><td><ix:nonfraction>41,198</ix:nonfraction></td><td>$</td><td><ix:nonfraction>37,678</ix:nonfraction></td><td>$</td><td><ix:nonfraction>134,161</ix:nonfraction></td><td>$</td><td><ix:nonfraction>125,381</ix:nonfraction></td></tr><tr><td>Operating income</td><td>$</td><td><ix:nonfraction>16,511</ix:nonfraction></td><td>$</td><td><ix:nonfraction>15,209</ix:nonfraction></td><td>$</td><td><ix:nonfraction>54,794</ix:nonfraction></td><td>$</td><td><ix:nonfraction>50,640</ix:nonfraction></td></tr><tr><td>Europe:</td></tr><tr><td>Net sales</td><td>$</td><td><ix:nonfraction>24,014</ix:nonfraction></td><td>$</td><td><ix:nonfraction>21,884</ix:nonfraction></td><td>$</td><td><ix:nonfraction>82,329</ix:nonfraction></td><td>$</td><td><ix:nonfraction>76,404</ix:nonfraction></td></tr><tr><td>Operating income</td><td>$</td><td><ix:nonfraction>10,501</ix:nonfraction></td><td>$</td><td><ix:nonfraction>9,170</ix:nonfraction></td><td>$</td><td><ix:nonfraction>35,424</ix:nonfraction></td><td>$</td><td><ix:nonfraction>31,872</ix:nonfraction></td></tr><tr><td>Greater China:</td></tr><tr><td>Net sales</td><td>$</td><td><ix:nonfraction>15,369</ix:nonfraction></td><td>$</td><td><ix:nonfraction>14,728</ix:nonfraction></td><td>$</td><td><ix:nonfraction>49,884</ix:nonfraction></td><td>$</td><td><ix:nonfraction>51,919</ix:nonfraction></td></tr><tr><td>Operating income</td><td>$</td><td><ix:nonfraction>5,822</ix:nonfraction></td><td>$</td><td><ix:nonfraction>5,562</ix:nonfraction></td><td>$</td><td><ix:nonfraction>20,608</ix:nonfraction></td><td>$</td><td><ix:nonfraction>20,884</ix:nonfraction></td></tr><tr><td>Japan:</td></tr><tr><td>Net sales</td><td>$</td><td><ix:nonfraction>5,782</ix:nonfraction></td><td>$</td><td><ix:nonfraction>5,097</ix:nonfraction></td><td>$</td><td><ix:nonfraction>22,067</ix:nonfraction></td><td>$</td><td><ix:nonfraction>19,126</ix:nonfraction></td></tr><tr><td>Operating income</td><td>$</td><td><ix:nonfraction>2,872</ix:nonfraction></td><td>$</td><td><ix:nonfraction>2,544</ix:nonfraction></td><td>$</td><td><ix:nonfraction>10,620</ix:nonfraction></td><td>$</td><td><ix:nonfraction>9,498</ix:nonfraction></td></tr><tr><td>Rest of Asia Pacific:</td></tr><tr><td>Net sales</td><td>$</td><td><ix:nonfraction>7,673</ix:nonfraction></td><td>$</td><td><ix:nonfraction>6,390</ix:nonfraction></td><td>$</td><td><ix:nonfraction>25,254</ix:nonfraction></td><td>$</td><td><ix:nonfraction>23,275</ix:nonfraction></td></tr><tr><td>Operating income</td><td>$</td><td><ix:nonfraction>3,243</ix:nonfraction></td><td>$</td><td><ix:nonfraction>2,610</ix:nonfraction></td><td>$</td><td><ix:nonfraction>10,813</ix:nonfraction></td><td>$</td><td><ix:nonfraction>9,995</ix:nonfraction></td></tr></table></div></ix:continuation></ix:nonnumeric><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 11</div></div></div><hr/><div><div><br/></div></div><ix:nonnumeric><ix:continuation><div>A reconciliation of the Companys segment operating income to the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 28, 2025 and June 29, 2024, is as follows (in millions):</div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Segment operating income</td><td>$</td><td><ix:nonfraction>38,949</ix:nonfraction></td><td>$</td><td><ix:nonfraction>35,095</ix:nonfraction></td><td>$</td><td><ix:nonfraction>132,259</ix:nonfraction></td><td>$</td><td><ix:nonfraction>122,889</ix:nonfraction></td></tr><tr><td>Research and development expense</td><td>(<ix:nonfraction>8,866</ix:nonfraction>)</td><td>(<ix:nonfraction>8,006</ix:nonfraction>)</td><td>(<ix:nonfraction>25,684</ix:nonfraction>)</td><td>(<ix:nonfraction>23,605</ix:nonfraction>)</td></tr><tr><td>Other corporate expenses, net</td><td>(<ix:nonfraction>1,881</ix:nonfraction>)</td><td>(<ix:nonfraction>1,737</ix:nonfraction>)</td><td>(<ix:nonfraction>5,952</ix:nonfraction>)</td><td>(<ix:nonfraction>5,659</ix:nonfraction>)</td></tr><tr><td>Total operating income</td><td>$</td><td><ix:nonfraction>28,202</ix:nonfraction></td><td>$</td><td><ix:nonfraction>25,352</ix:nonfraction></td><td>$</td><td><ix:nonfraction>100,623</ix:nonfraction></td><td>$</td><td><ix:nonfraction>93,625</ix:nonfraction></td></tr></table></div></ix:continuation></ix:nonnumeric><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 12</div></div></div><hr/><div><div><br/></div></div><div>Item 2.Managements Discussion and Analysis of Financial Condition and Results of Operations</div><div>This Item and other sections of this Quarterly Report on Form 10-Q (Form 10-Q) contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. For example, statements in this Form 10-Q regarding the potential future impact of macroeconomic conditions and tariffs and other measures on the Companys business and results of operations are forward-looking statements. Forward-looking statements can also be identified by words such as future, anticipates, believes, estimates, expects, intends, plans, predicts, will, would, could, can, may, and similar terms. Forward-looking statements are not guarantees of future performance and the Companys actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A of the 2024 Form 10-K and Part II, Item 1A of this Form 10-Q, in each case under the heading Risk Factors. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.</div><div>Unless otherwise stated, all information presented herein is based on the Companys fiscal calendar, and references to particular years, quarters, months or periods refer to the Companys fiscal years ended in September and the associated quarters, months and periods of those fiscal years.</div><div>The following discussion should be read in conjunction with the 2024 Form 10-K filed with the U.S. Securities and Exchange Commission (the SEC) and the condensed consolidated financial statements and accompanying notes included in Part I, Item 1 of this Form 10-Q.</div><div>Available Information</div><div>The Company periodically provides certain information for investors on its corporate website, www.apple.com, and its investor relations website, investor.apple.com. This includes press releases and other information about financial performance, information on corporate governance, and details related to the Companys annual meeting of shareholders. The information contained on the websites referenced in this Form 10-Q is not incorporated by reference into this filing. Further, the Companys references to website URLs are intended to be inactive textual references only.</div><div>Business Seasonality and Product Introductions</div><div>The Company has historically experienced higher net sales in its first quarter compared to other quarters in its fiscal year due in part to seasonal holiday demand. Additionally, new product and service introductions can significantly impact net sales, cost of sales and operating expenses. The timing of product introductions can also impact the Companys net sales to its indirect distribution channels as these channels are filled with new inventory following a product launch, and channel inventory of an older product often declines as the launch of a newer product approaches. Net sales can also be affected when consumers and distributors anticipate a product introduction.</div><div>During the third quarter of 2025, the Company announced iOS 26, macOS Tahoe 26, iPadOS 26, watchOS 26, visionOS 26 and tvOS 26.</div><div>Macroeconomic Conditions</div><div>Macroeconomic conditions, including inflation, interest rates and currency fluctuations, have directly and indirectly impacted, and could in the future materially impact, the Companys results of operations and financial condition.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 13</div></div></div><hr/><div><div><br/></div></div><div>Tariffs and Other Measures</div><div>Beginning in the second quarter of 2025, new tariffs were announced on imports to the U.S. (U.S. Tariffs), including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the European Union (EU), among others. In response, several countries have imposed, or threatened to impose, reciprocal tariffs on imports from the U.S. and other retaliatory measures. Various modifications to the U.S. Tariffs have been announced and further changes could be made in the future, which may include additional sector-based tariffs or other measures. For example, the U.S. Department of Commerce has initiated an investigation under Section 232 of the Trade Expansion Act of 1962, as amended, into, among other things, imports of semiconductors, semiconductor manufacturing equipment, and their derivative products, including downstream products that contain semiconductors. Tariffs and other measures that are applied to the Companys products or their components can have a material adverse impact on the Companys business, results of operations and financial condition, including impacting the Companys supply chain, the availability of rare earths and other raw materials and components, pricing and gross margin. The ultimate impact remains uncertain and will depend on several factors, including whether additional or incremental U.S. Tariffs or other measures are announced or imposed, to what extent other countries implement tariffs or other retaliatory measures in response, and the overall magnitude and duration of these measures. Trade and other international disputes can have an adverse impact on the overall macroeconomic environment and result in shifts and reductions in consumer spending and negative consumer sentiment for the Companys products and services, all of which can further adversely affect the Companys business and results of operations.</div><div>Segment Operating Performance</div><div>The following table shows net sales by reportable segment for the three- and nine-month periods ended June 28, 2025 and June29, 2024 (dollars in millions):</div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>Change</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>Change</td></tr><tr><td>Americas</td><td>$</td><td>41,198</td><td>$</td><td>37,678</td><td>9</td><td>%</td><td>$</td><td>134,161</td><td>$</td><td>125,381</td><td>7</td><td>%</td></tr><tr><td>Europe</td><td>24,014</td><td>21,884</td><td>10</td><td>%</td><td>82,329</td><td>76,404</td><td>8</td><td>%</td></tr><tr><td>Greater China</td><td>15,369</td><td>14,728</td><td>4</td><td>%</td><td>49,884</td><td>51,919</td><td>(4)</td><td>%</td></tr><tr><td>Japan</td><td>5,782</td><td>5,097</td><td>13</td><td>%</td><td>22,067</td><td>19,126</td><td>15</td><td>%</td></tr><tr><td>Rest of Asia Pacific</td><td>7,673</td><td>6,390</td><td>20</td><td>%</td><td>25,254</td><td>23,275</td><td>9</td><td>%</td></tr><tr><td>Total net sales</td><td>$</td><td>94,036</td><td>$</td><td>85,777</td><td>10</td><td>%</td><td>$</td><td>313,695</td><td>$</td><td>296,105</td><td>6</td><td>%</td></tr></table></div><div>Americas</div><div>Americas net sales increased during the third quarter and first nine months of 2025 compared to the same periods in 2024 due primarily to higher net sales of iPhone and Services. The weakness in foreign currencies relative to the U.S. dollar had an unfavorable year-over-year impact on Americas net sales during the third quarter and first nine months of 2025.</div><div>Europe</div><div>Europe net sales increased during the third quarter and first nine months of 2025 compared to the same periods in 2024 due primarily to higher net sales of Services and iPhone.</div><div>Greater China</div><div>Greater China net sales increased during the third quarter of 2025 compared to the third quarter of 2024 due primarily to higher net sales of iPhone and Mac. Greater China net sales decreased during the first nine months of 2025 compared to the same period in 2024 due to lower net sales of iPhone, partially offset by higher net sales of Mac.</div><div>Japan</div><div>Japan net sales increased during the third quarter and first nine months of 2025 compared to the same periods in 2024 due primarily to higher net sales of iPhone and Services. The strength in the yen relative to the U.S. dollar had a favorable year-over-year impact on Japan net sales during the third quarter of 2025.</div><div>Rest of Asia Pacific</div><div>Rest of Asia Pacific net sales increased during the third quarter and first nine months of 2025 compared to the same periods in 2024 due primarily to higher net sales of Services and iPhone.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 14</div></div></div><hr/><div><div><br/></div></div><div>Products and Services Performance</div><div>The following table shows net sales by category for the three- and nine-month periods ended June 28, 2025 and June29, 2024 (dollars in millions):</div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>Change</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>Change</td></tr><tr><td>iPhone</td><td>$</td><td>44,582</td><td>$</td><td>39,296</td><td>13</td><td>%</td><td>$</td><td>160,561</td><td>$</td><td>154,961</td><td>4</td><td>%</td></tr><tr><td>Mac</td><td>8,046</td><td>7,009</td><td>15</td><td>%</td><td>24,982</td><td>22,240</td><td>12</td><td>%</td></tr><tr><td>iPad</td><td>6,581</td><td>7,162</td><td>(8)</td><td>%</td><td>21,071</td><td>19,744</td><td>7</td><td>%</td></tr><tr><td>Wearables, Home and Accessories</td><td>7,404</td><td>8,097</td><td>(9)</td><td>%</td><td>26,673</td><td>27,963</td><td>(5)</td><td>%</td></tr><tr><td>Services</td><td>27,423</td><td>24,213</td><td>13</td><td>%</td><td>80,408</td><td>71,197</td><td>13</td><td>%</td></tr><tr><td>Total net sales</td><td>$</td><td>94,036</td><td>$</td><td>85,777</td><td>10</td><td>%</td><td>$</td><td>313,695</td><td>$</td><td>296,105</td><td>6</td><td>%</td></tr></table></div><div>iPhone</div><div>iPhone net sales increased during the third quarter and first nine months of 2025 compared to the same periods in 2024 due to higher net sales of Pro models.</div><div>Mac</div><div>Mac net sales increased during the third quarter and first nine months of 2025 compared to the same periods in 2024 due to higher net sales of both laptops and desktops.</div><div>iPad</div><div>iPad net sales decreased during the third quarter of 2025 compared to the third quarter of 2024 due to lower net sales of iPad Pro, partially offset by higher net sales of all other iPad models. iPad net sales increased during the first nine months of 2025 compared to the same period in 2024 due primarily to higher net sales of iPad Air.</div><div>Wearables, Home and Accessories</div><div>Wearables, Home and Accessories net sales decreased during the third quarter and first nine months of 2025 compared to the same periods in 2024 due primarily to lower net sales of Wearables and Accessories.</div><div>Services</div><div>Services net sales increased during the third quarter and first nine months of 2025 compared to the same periods in 2024 due primarily to higher net sales from advertising, the App Store and cloud services.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 15</div></div></div><hr/><div><div><br/></div></div><div>Gross Margin</div><div>Products and Services gross margin and gross margin percentage for the three- and nine-month periods ended June 28, 2025 and June29, 2024, were as follows (dollars in millions):</div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Gross margin:</td></tr><tr><td>Products</td><td>$</td><td>22,993</td><td>$</td><td>21,761</td><td>$</td><td>86,190</td><td>$</td><td>84,241</td></tr><tr><td>Services</td><td>20,725</td><td>17,917</td><td>60,670</td><td>52,563</td></tr><tr><td>Total gross margin</td><td>$</td><td>43,718</td><td>$</td><td>39,678</td><td>$</td><td>146,860</td><td>$</td><td>136,804</td></tr></table></div><div><table><tr><td>Gross margin percentage:</td></tr><tr><td>Products</td><td>34.5</td><td>%</td><td>35.3</td><td>%</td><td>36.9</td><td>%</td><td>37.5</td><td>%</td></tr><tr><td>Services</td><td>75.6</td><td>%</td><td>74.0</td><td>%</td><td>75.5</td><td>%</td><td>73.8</td><td>%</td></tr><tr><td>Total gross margin percentage</td><td>46.5</td><td>%</td><td>46.3</td><td>%</td><td>46.8</td><td>%</td><td>46.2</td><td>%</td></tr></table></div><div>Products Gross Margin</div><div>Products gross margin increased during the third quarter of 2025 compared to the third quarter of 2024 due primarily to a different mix of products and favorable costs, partially offset by tariffs. Products gross margin increased during the first nine months of 2025 compared to the same period in 2024 due primarily to favorable costs and a different mix of products, partially offset by tariffs and the weakness in foreign currencies relative to the U.S. dollar.</div><div>Products gross margin percentage decreased during the third quarter of 2025 compared to the third quarter of 2024 due primarily to tariffs and a different mix of products, partially offset by favorable costs. Products gross margin percentage decreased during the first nine months of 2025 compared to the same period in 2024 due primarily to a different mix of products and tariffs, partially offset by favorable costs.</div><div>Services Gross Margin</div><div>Services gross margin increased during the third quarter and first nine months of 2025 compared to the same periods in 2024 due primarily to higher Services net sales and a different mix of services.</div><div>Services gross margin percentage increased during the third quarter and first nine months of 2025 compared to the same periods in 2024 due primarily to a different mix of services, partially offset by higher costs.</div><div>The Companys future gross margins can be impacted by a variety of factors, as discussed in Part I, Item 1A of the 2024 Form 10-K and Part II, Item 1A of this Form 10-Q, in each case under the heading Risk Factors. As a result, the Company believes, in general, gross margins will be subject to volatility and downward pressure.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 16</div></div></div><hr/><div><div><br/></div></div><div>Operating Expenses</div><div>Operating expenses for the three- and nine-month periods ended June 28, 2025 and June29, 2024, were as follows (dollars in millions):</div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Research and development</td><td>$</td><td>8,866</td><td>$</td><td>8,006</td><td>$</td><td>25,684</td><td>$</td><td>23,605</td></tr><tr><td>Percentage of total net sales</td><td>9</td><td>%</td><td>9</td><td>%</td><td>8</td><td>%</td><td>8</td><td>%</td></tr><tr><td>Selling, general and administrative</td><td>$</td><td>6,650</td><td>$</td><td>6,320</td><td>$</td><td>20,553</td><td>$</td><td>19,574</td></tr><tr><td>Percentage of total net sales</td><td>7</td><td>%</td><td>7</td><td>%</td><td>7</td><td>%</td><td>7</td><td>%</td></tr><tr><td>Total operating expenses</td><td>$</td><td>15,516</td><td>$</td><td>14,326</td><td>$</td><td>46,237</td><td>$</td><td>43,179</td></tr><tr><td>Percentage of total net sales</td><td>17</td><td>%</td><td>17</td><td>%</td><td>15</td><td>%</td><td>15</td><td>%</td></tr></table></div><div>Research and Development</div><div>The growth in research and development (R&amp;D) expense during the third quarter and first nine months of 2025 compared to the same periods in 2024 was driven primarily by increases in headcount-related expenses and infrastructure-related costs.</div><div>Selling, General and Administrative</div><div>The growth in selling, general and administrative expense during the third quarter and first nine months of 2025 compared to the same periods in 2024 was driven primarily by increases in headcount-related expenses and variable selling expenses.</div><div>Provision for Income Taxes</div><div>Provision for income taxes, effective tax rate and statutory federal income tax rate for the three- and nine-month periods ended June 28, 2025 and June29, 2024, were as follows (dollars in millions):</div><div><table><tr><td>Three Months Ended</td><td>Nine Months Ended</td></tr><tr><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td><td>June 28,<br/>2025</td><td>June 29,<br/>2024</td></tr><tr><td>Provision for income taxes</td><td>$</td><td>4,597</td><td>$</td><td>4,046</td><td>$</td><td>15,381</td><td>$</td><td>14,875</td></tr><tr><td>Effective tax rate</td><td>16.4</td><td>%</td><td>15.9</td><td>%</td><td>15.4</td><td>%</td><td>15.8</td><td>%</td></tr><tr><td>Statutory federal income tax rate</td><td>21</td><td>%</td><td>21</td><td>%</td><td>21</td><td>%</td><td>21</td><td>%</td></tr></table></div><div>The Companys effective tax rate for the third quarter of 2025 was lower than the statutory federal income tax rate due primarily to a lower effective tax rate on foreign earnings, the impact of the U.S. federal R&amp;D credit, and tax benefits from share-based compensation, partially offset by state income taxes. The Companys effective tax rate for the first nine months of 2025 was lower than the statutory federal income tax rate due primarily to a lower effective tax rate on foreign earnings, including the impact of changes in unrecognized tax benefits, tax benefits from share-based compensation, and the impact of the U.S. federal R&amp;D credit, partially offset by state income taxes.</div><div>The Companys effective tax rate for the third quarter of 2025 was higher compared to the third quarter of 2024 due primarily to the impact from foreign currency revaluations of unrecognized tax benefits. The Companys effective tax rate for the first nine months of 2025 was lower compared to the same period in 2024 due primarily to the impact of changes in unrecognized tax benefits, partially offset by a higher effective tax rate on foreign earnings.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 17</div></div></div><hr/><div><div><br/></div></div><div>Liquidity and Capital Resources</div><div>The Company believes its balances of cash, cash equivalents and marketable securities, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.</div><div>The Companys contractual cash requirements have not changed materially since the 2024 Form 10-K, except for manufacturing purchase obligations and the State Aid Decision tax payable.</div><div>Manufacturing Purchase Obligations</div><div>The Company utilizes several outsourcing partners to manufacture subassemblies for the Companys products and to perform final assembly and testing of finished products. The Company also obtains individual components for its products from a wide variety of individual suppliers. As of June28, 2025, the Company had manufacturing purchase obligations of $44.1 billion, with $43.8 billion payable within 12 months.</div><div>State Aid Decision Tax Payable</div><div>During the first nine months of 2025, the Company released from escrow 14.2billion, or $15.4 billion, to Ireland in connection with the State Aid Decision, which fully settled the obligation.</div><div>Capital Return Program</div><div>In addition to its contractual cash requirements, the Company has authorized share repurchase programs. The programs do not obligate the Company to acquire a minimum amount of shares. As of June28, 2025, the Companys quarterly cash dividend was $0.26 per share. The Company intends to increase its dividend on an annual basis, subject to declaration by the Board of Directors.</div><div>During the third quarter of 2025, the Company repurchased $21.0 billion of its common stock and paid dividends and dividend equivalents of $3.9 billion.</div><div>Recent Accounting Pronouncements</div><div>Disaggregation of Income Statement Expenses</div><div>In November 2024, the Financial Accounting Standards Board (the FASB) issued Accounting Standards Update (ASU) No. 2024-03, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03) and in January 2025, the FASB issued ASU No. 2025-01, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require the Company to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the Consolidated Statements of Operations, as well as qualitatively describe remaining amounts included in those captions. ASU 2024-03 will also require the Company to disclose both the amount and the Companys definition of selling expenses. The Company will adopt ASU 2024-03 in its fourth quarter of 2028 using a prospective transition method.</div><div>Income Taxes</div><div>In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The Company will adopt ASU 2023-09 in its fourth quarter of 2026 using a prospective transition method.</div><div>Segment Reporting</div><div>In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which will require the Company to disclose segment expenses that are significant and regularly provided to the Companys chief operating decision maker (CODM). In addition, ASU 2023-07 will require the Company to disclose the title and position of its CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. The Company will adopt ASU 2023-07 in its fourth quarter of 2025 using a retrospective transition method.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 18</div></div></div><hr/><div><div><br/></div></div><div>Critical Accounting Estimates</div><div>The preparation of financial statements and related disclosures in conformity with GAAP and the Companys discussion and analysis of its financial condition and operating results require the Companys management to make judgments, assumptions and estimates that affect the amounts reported. Note 1, Summary of Significant Accounting Policies of the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Form 10-Q and in the Notes to Consolidated Financial Statements in Part II, Item 8 of the 2024 Form 10-K describe the significant accounting policies and methods used in the preparation of the Companys condensed consolidated financial statements. There have been no material changes to the Companys critical accounting estimates since the 2024 Form 10-K.</div><div>Item 3.Quantitative and Qualitative Disclosures About Market Risk</div><div>There have been no material changes to the Companys market risk during the first nine months of 2025. For a discussion of the Companys exposure to market risk, refer to the Companys market risk disclosures set forth in Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk of the 2024 Form 10-K.</div><div>Item 4.Controls and Procedures</div><div>Evaluation of Disclosure Controls and Procedures</div><div>Based on an evaluation under the supervision and with the participation of the Companys management, the Companys principal executive officer and principal financial officer have concluded that the Companys disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act were effective as of June28, 2025 to provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i)recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and (ii)accumulated and communicated to the Companys management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.</div><div>Changes in Internal Control over Financial Reporting</div><div>There were no changes in the Companys internal control over financial reporting during the third quarter of 2025, which were identified in connection with managements evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 19</div></div></div><hr/><div><div><br/></div></div><div>PART II  OTHER INFORMATION</div><div>Item 1.Legal Proceedings</div><div>Digital Markets Act Investigations</div><div>On March 25, 2024, the Commission announced that it had opened a formal noncompliance investigation against the Company under Article 5(4) of the EU Digital Markets Act (the DMA) (the Article 5(4) Investigation). The Article 5(4) Investigation relates to how developers may communicate and promote offers to end users for apps distributed through the App Store, as well as how developers may conclude contracts with those end users. On June 24, 2024, the Commission announced that it had opened an additional formal investigation against the Company regarding whether the Companys new contractual requirements for third-party app developers and app marketplaces may violate the DMA (the Article 6(4) Investigation). On April 23, 2025, the Commission fined the Company 500 million in the Article 5(4) Investigation and issued a cease and desist order requiring the Company to remove technical and commercial restrictions that prevent developers from steering users to alternative distribution channels outside the App Store. The Company has appealed the Commissions Article 5(4) decision. Also on April 23, 2025, the Commission issued preliminary findings in the Article 6(4) Investigation. If the Commission makes a final determination in the Article 6(4) Investigation that there has been a violation, it can issue a cease and desist order and may impose fines up to 10% of the Companys annual worldwide net sales. The Commission may also seek to impose additional fines if it deems that the Company has violated a cease and desist order. The Company believes that it complies with the DMA and has continued to make changes to its compliance plan in response to feedback and engagement with the Commission.</div><div>Department of Justice Lawsuit</div><div>On March 21, 2024, the U.S. Department of Justice (the DOJ) and a number of state and district attorneys general filed a civil antitrust lawsuit in the U.S. District Court for the District of New Jersey against the Company alleging monopolization or attempted monopolization in the markets for performance smartphones and smartphones in violation of U.S. antitrust laws. The DOJ is seeking equitable relief to redress the alleged anticompetitive behavior. In addition, various civil litigation matters have been filed in state and federal courts in the U.S. alleging similar violations of U.S. antitrust laws and seeking monetary damages and other nonmonetary relief. The Company believes it has substantial defenses and intends to vigorously defend itself.</div><div>Epic Games</div><div>Epic Games, Inc. (Epic) filed a lawsuit in the U.S. District Court for the Northern District of California (the California District Court) against the Company alleging violations of federal and state antitrust laws and Californias unfair competition law based upon the Companys operation of its App Store. The California District Court found that certain provisions of the Companys App Review Guidelines violate Californias unfair competition law and issued an injunction (the 2021 Injunction) enjoining the Company from prohibiting developers from including in their apps buttons, external links, or other calls to action that direct customers to purchasing mechanisms other than the Companys in-app purchase system. The 2021 Injunction applies to apps on the U.S. storefronts of the iOS and iPadOS App Stores. On January 16, 2024, the Company implemented a plan to comply with the 2021 Injunction and filed a statement of compliance with the California District Court. On September 30, 2024, the Company filed a motion with the California District Court to narrow or vacate the 2021 Injunction. On April 30, 2025, the California District Court found the Company to be in violation of the 2021 Injunction and enjoined the Company from imposing any commission or any fee on purchases that consumers make outside an app; restricting, conditioning, limiting, or prohibiting how developers guide consumers to purchases outside an app; or otherwise interfering with a consumers choice to proceed in or out of an app. The California District Court also denied the Companys motion to narrow or vacate the 2021 Injunction and referred the Company to the U.S. Attorney for the Northern District of California for a determination whether criminal contempt proceedings are appropriate. The Company will continue to vigorously defend its actions and employees, and has appealed the California District Courts most recent decision to the U.S. Court of Appeals for the Ninth Circuit (the Ninth Circuit Court). Although the Companys request to stay the decision pending appeal was denied, the Ninth Circuit Court has agreed to consider the Companys appeal on an expedited basis, with arguments scheduled for October 2025.</div><div>Other Legal Proceedings</div><div>The Company is subject to other legal proceedings and claims that have not been fully resolved and that have arisen in the ordinary course of business. The Company settled certain matters during the third quarter of 2025 that did not individually or in the aggregate have a material impact on the Companys financial condition or operating results. The outcome of litigation is inherently uncertain. If one or more legal matters were resolved against the Company in a reporting period for amounts above managements expectations, the Companys financial condition and operating results for that reporting period could be materially adversely affected.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 20</div></div></div><hr/><div><div><br/></div></div><div>Item 1A.Risk Factors</div><div>The Companys business, reputation, results of operations, financial condition and stock price can be affected by a number of factors, whether currently known or unknown, including those described in Part I, Item 1A of the 2024 Form 10-K and Part II, Item 1A of the Forms 10-Q for the quarters ended December 28, 2024 (the first quarter 2025 Form 10-Q) and March 29, 2025 (the second quarter 2025 Form 10-Q), in each case under the heading Risk Factors. When any one or more of these risks materialize from time to time, the Companys business, reputation, results of operations, financial condition and stock price can be materially and adversely affected. Except for the risk factors disclosed in Part II, Item 1A of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000320193/000032019325000008/aapl-20241228.htm">first quarter 2025 Form 10-Q</a> and the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000320193/000032019325000057/aapl-20250329.htm">second</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000320193/000032019325000057/aapl-20250329.htm"> quarter 2025 Form 10-Q</a>, which are hereby incorporated by reference into this Part II, Item 1A of this Form 10-Q, there have been no material changes to the Companys risk factors since the 2024 Form 10-K.</div><div>Item 2.Unregistered Sales of Equity Securities and Use of Proceeds</div><div>Purchases of Equity Securities by the Issuer and Affiliated Purchasers</div><div>Share repurchase activity during the three months ended June28, 2025, was as follows (in millions, except number of shares, which are reflected in thousands, and per-share amounts):</div><div><table><tr><td>Periods</td><td>Total Number<br/>of Shares Purchased</td><td>Average Price<br/>Paid Per Share</td><td>Total Number of Shares<br/>Purchased as Part of Publicly<br/>Announced Plans or Programs</td><td><div>Approximate Dollar Value of</div><div>Shares That May Yet Be Purchased</div><div>Under the Plans or Programs (1)</div></td></tr><tr><td><div>March 30, 2025 to May 3, 2025:</div></td></tr><tr><td>Open market and privately negotiated purchases</td><td>43,161</td><td>$</td><td>200.79</td><td>43,161</td></tr><tr><td><div>May 4, 2025 to May 31, 2025:</div></td></tr><tr><td>Open market and privately negotiated purchases</td><td>28,223</td><td>$</td><td>203.17</td><td>28,223</td></tr><tr><td><div>June 1, 2025 to June 28, 2025:</div></td></tr><tr><td>Open market and privately negotiated purchases</td><td>32,880</td><td>$</td><td>200.73</td><td>32,880</td></tr><tr><td>Total</td><td>104,264</td><td>$</td><td>119,779</td></tr></table></div><div>(1)On May 2, 2024, the Company announced a program to repurchase up to $110 billion of the Companys common stock. As of June28, 2025, remaining availability under the May 2024 program was $19.8 billion. On May 1, 2025, the Company announced an additional program to repurchase up to $100 billion of the Companys common stock. The programs do not obligate the Company to acquire a minimum amount of shares. Under the programs, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act.</div><div>Item 3.Defaults Upon Senior Securities</div><div>None.</div><div>Item 4.Mine Safety Disclosures</div><div>Not applicable.</div><div>Item 5.Other Information</div><div>Insider Trading Arrangements</div><div><ix:nonnumeric><ix:nonnumeric><ix:nonnumeric><ix:nonnumeric>None.</ix:nonnumeric></ix:nonnumeric></ix:nonnumeric></ix:nonnumeric></div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 21</div></div></div><hr/><div><div><br/></div></div><div>Item 6.Exhibits</div><div><table><tr><td>Incorporated by Reference</td></tr><tr><td><div><br/></div><div>Exhibit</div><div>Number</div></td><td>Exhibit Description</td><td>Form</td><td>Exhibit</td><td>Filing Date/<br/>Period End Date</td></tr><tr><td><div>4.1</div></td><td><div><a href="https://www.sec.gov/Archives/edgar/data/320193/000114036125018400/ef20048691_ex4-1.htm">Officers Certificate of the Registrant, dated as of May 12, 2025, including forms of global notes representing the 4.000% Notes due 2028, 4.200% Notes due 2030, 4.500% Notes due 2032 and 4.750% Notes due 2035.</a></div></td><td><div>8-K</div></td><td>4.1</td><td>5/12/25</td></tr><tr><td><div>31.1*</div></td><td><div><a href="a10-qexhibit31106282025.htm">Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.</a></div></td></tr><tr><td><div>31.2*</div></td><td><div><a href="a10-qexhibit31206282025.htm">Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.</a></div></td></tr><tr><td><div>32.1**</div></td><td><div><a href="a10-qexhibit32106282025.htm">Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer.</a></div></td></tr><tr><td><div>101*</div></td><td><div>Inline XBRL Document Set for the condensed consolidated financial statements and accompanying notes in Part I, Item 1, Financial Statements of this Quarterly Report on Form 10-Q.</div></td></tr><tr><td><div>104*</div></td><td><div>Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.</div></td></tr></table></div><div>*Filed herewith.</div><div>**Furnished herewith.</div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 22</div></div></div><hr/><div><div><br/></div></div><div>SIGNATURE</div><div>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div><div><table><tr><td><div>Date: August1, 2025</div></td><td>Apple Inc.</td></tr><tr><td>By:</td><td><div>/s/ Kevan Parekh</div></td></tr><tr><td><div>Kevan Parekh</div></td></tr><tr><td>Senior Vice President,<br/>Chief Financial Officer</td></tr></table></div><div><div><div>Apple Inc. | Q3 2025 Form 10-Q | 23</div></div></div></body>